BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441-2447. [PMID: 15161894 DOI: 10.1001/jama.291.20.2441] [Cited by in Crossref: 792] [Cited by in F6Publishing: 673] [Article Influence: 46.6] [Reference Citation Analysis]
Number Citing Articles
1 Janssen-heijnen ML, Maas HA, Koning CC, van der Bruggen-bogaarts BA, Groen HJ, Wymenga AM. Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer. Journal of Geriatric Oncology 2014;5:71-7. [DOI: 10.1016/j.jgo.2013.07.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
2 Osbeck Sandblom H, Dotevall H, Svennerholm K, Tuomi L, Finizia C. Characterization of dysphagia and laryngeal findings in COVID-19 patients treated in the ICU-An observational clinical study. PLoS One 2021;16:e0252347. [PMID: 34086717 DOI: 10.1371/journal.pone.0252347] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wong A, Zhu D, Kraus D, Tham T. Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis. Laryngoscope 2021;131:333-41. [PMID: 32220072 DOI: 10.1002/lary.28616] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Mallouppas M, Walker JM, Guha A, Dobson R, Ghosh AK. Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage them. Br J Hosp Med (Lond) 2020;81:1-11. [PMID: 32990088 DOI: 10.12968/hmed.2020.0269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Muscaritoli M, Molfino A, Rossi Fanelli F. Muscle depletion and the prediction of chemotherapy toxicity. Intern Emerg Med 2013;8:373-5. [DOI: 10.1007/s11739-013-0966-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Houterman S, Janssen-heijnen MLG, Verheij CDGW, Kil PJM, van den Berg HA, Coebergh JW. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer Prostatic Dis 2006;9:179-84. [DOI: 10.1038/sj.pcan.4500868] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
7 Alibhai SMH, Leach M, Minden MD, Brandwein J. Outcomes and quality of care in acute myeloid leukemia over 40 years. Cancer 2009;115:2903-11. [DOI: 10.1002/cncr.24373] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
8 Tooth L, Hockey R, Byles J, Dobson A. Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women. Journal of Clinical Epidemiology 2008;61:151-9. [DOI: 10.1016/j.jclinepi.2007.05.015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
9 Sasaki K, Jabbour EJ, Ravandi F, Konopleva M, Borthakur G, Wierda WG, Daver N, Takahashi K, Naqvi K, DiNardo C, Montalban-Bravo G, Kanagal-Shamanna R, Issa G, Jain P, Skinner J, Rios MB, Pierce S, Soltysiak KA, Sato J, Garcia-Manero G, Cortes JE. The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes. Am J Hematol 2021;96:241-50. [PMID: 33180322 DOI: 10.1002/ajh.26047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Marventano S, Grosso G, Mistretta A, Bogusz-Czerniewicz M, Ferranti R, Nolfo F, Giorgianni G, Rametta S, Drago F, Basile F. Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis. 2014;29:1159-1169. [PMID: 25064390 DOI: 10.1007/s00384-014-1972-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
11 Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. J Gastrointest Surg 2016;20:1975-85. [PMID: 27730398 DOI: 10.1007/s11605-016-3286-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
12 DeWees TA, Nikitas J, Rehman S, Bradley JD, Robinson CG, Roach MC. Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy. Pract Radiat Oncol 2019;9:e83-9. [PMID: 30244094 DOI: 10.1016/j.prro.2018.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gironés R, Torregrosa D, Gómez-Codina J, Maestu I, Tenias JM, Rosell R. Prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores. Lung Cancer 2011;72:108-13. [PMID: 20727613 DOI: 10.1016/j.lungcan.2010.07.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
14 Japuntich SJ, Kumar P, Pendergast JF, Juarez Caballero GY, Malin JL, Wallace RB, Chrischilles EA, Keating NL, Park ER. Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients. Nicotine Tob Res 2019;21:497-504. [PMID: 29351659 DOI: 10.1093/ntr/nty012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
15 Brunello A, Fontana A, Zafferri V, Panza F, Fiduccia P, Basso U, Copetti M, Lonardi S, Roma A, Falci C, Monfardini S, Cella A, Pilotto A, Zagonel V. Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients. J Cancer Res Clin Oncol 2016;142:1069-77. [PMID: 26758276 DOI: 10.1007/s00432-015-2088-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
16 Peters TT, van Dijk BA, Roodenburg JL, Plaat BE, Wedman J, van der Laan BF, Halmos GB. Predictors of postoperative complications and survival in patients with major salivary glands malignancies: a study highlighting the influence of age. Head Neck 2014;36:369-74. [PMID: 23765432 DOI: 10.1002/hed.23304] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
17 Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bertetto O, Novello S, Migliorino MR, Favaretto A, Spatafora M, Ferraù F, Frontini L, Bearz A, Repetto L, Gridelli C, Barletta E, Barzelloni ML, Iaffaioli RV, De Maio E, Di Maio M, De Feo G, Sigoriello G, Chiodini P, Cioffi A, Guardasole V, Angelini V, Rossi A, Bilancia D, Germano D, Lamberti A, Pontillo V, Brancaccio L, Renda F, Romano F, Esani G, Gambaro A, Vinante O, Azzarello G, Clerici M, Bollina R, Belloni P, Sannicolò M, Ciuffreda L, Parello G, Cabiddu M, Sacco C, Sibau A, Porcile G, Castiglione F, Ostellino O, Monfardini S, Stefani M, Scagliotti G, Selvaggi G, De Marinis F, Martelli O, Gasparini G, Morabito A, Gattuso D, Colucci G, Galetta D, Giotta F, Gebbia V, Borsellino N, Testa A, Malaponte E, Capuano MA, Angiolillo M, Sollitto F, Tirelli U, Spazzapan S, Adamo V, Altavilla G, Scimone A, Hopps MR, Tartamella F, Ianniello GP, Tinessa V, Failla G, Bordonaro R, Gebbia N, Valerio MR, D'Aprile M, Veltri E, Tonato M, Darwish S, Romito S, Carrozza F, Barni S, Ardizzoia A, Corradini GM, Pavia G, Belli M, Colantuoni G, Galligioni E, Caffo O, Labianca R, Quadri A, Cortesi E, D'Auria G, Fava S, Calcagno A, Luporini G, Locatelli MC, Di Costanzo F, Gasperoni S, Isa L, Candido P, Gaion F, Palazzolo G, Nettis G, Annamaria A, Rinaldi M, Lopez M, Felletti R, Di Negro GB, Rossi N, Calandriello A, Maiorino L, Mattioli R, Celano A, Schiavon S, Illiano A, Raucci CA, Caruso M, Foa P, Tonini G, Curcio C, Cazzaniga M. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005;23:6865-72. [PMID: 16192578 DOI: 10.1200/JCO.2005.02.527] [Cited by in Crossref: 356] [Cited by in F6Publishing: 96] [Article Influence: 22.3] [Reference Citation Analysis]
18 Karadaghy OA, Kallogjeri D, Piccirillo JF. Development of a New Clinical Severity Staging System for Patients With Nonmetastatic Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg 2017;143:1173-80. [PMID: 28449113 DOI: 10.1001/jamaoto.2017.0550] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25:1824-1831. [PMID: 17488980 DOI: 10.1200/jco.2007.10.6559] [Cited by in Crossref: 599] [Cited by in F6Publishing: 171] [Article Influence: 42.8] [Reference Citation Analysis]
20 Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng J, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics 2016;96:1028-36. [DOI: 10.1016/j.ijrobp.2016.08.023] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 13.4] [Reference Citation Analysis]
21 Niedersüß-Beke D, Orlinger M, Falch D, Heiler C, Piringer G, Thaler J, Hilbe W, Petzer A, Rumpold H. Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age. Cancers (Basel) 2021;13:2091. [PMID: 33925931 DOI: 10.3390/cancers13092091] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hamilton AS, Fleming ST, Wang D, Goodman M, Wu XC, Owen JB, Lo M, Ho A, Anderson RT, Thompson T. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer. Am J Clin Oncol 2016;39:55-63. [PMID: 24390274 DOI: 10.1097/COC.0000000000000017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
23 Michallet A, Cazin B, Bouvet E, Oberic L, Schlaifer D, Mosser L, Salles G, Coiffier B, Laurent G, Ysebaert L. First immunochemotherapy outcomes in elderly patients with CLL: A retrospective analysis. Journal of Geriatric Oncology 2013;4:141-7. [DOI: 10.1016/j.jgo.2013.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
24 Charlton ME, Stitzenberg KB, Lin C, Schlichting JA, Halfdanarson TR, Juarez GY, Pendergast JF, Chrischilles EA, Wallace RB. Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium. J Oncol Pract 2015;11:e476-86. [PMID: 26080831 DOI: 10.1200/JOP.2015.004564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME. Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data. Cancer Causes Control 2013;24:1985-94. [PMID: 23934001 DOI: 10.1007/s10552-013-0274-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
26 Choi SH, Terrell JE, Fowler KE, McLean SA, Ghanem T, Wolf GT, Bradford CR, Taylor J, Duffy SA. Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients. PLoS One 2016;11:e0149886. [PMID: 26930647 DOI: 10.1371/journal.pone.0149886] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 11.2] [Reference Citation Analysis]
27 Markman M. Recent reminders of why the gold standard for clinical research in oncology is the well-designed and conducted randomized phase III trial. Curr Oncol Rep 2004;6:421-2. [DOI: 10.1007/s11912-004-0070-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Gan SJ, Dahlstrom KR, Peck BW, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013;119:2593-2601. [PMID: 23605777 DOI: 10.1002/cncr.28107] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
29 Wildes TM, Kallogjeri D, Powers B, Vlahiotis A, Mutch M, Spitznagel EL Jr, Tan B, Piccirillo JF. The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity. J Geriatr Oncol 2010;1:48-56. [PMID: 21113435 DOI: 10.1016/j.jgo.2010.08.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
30 Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912-2919. [PMID: 15994282 DOI: 10.1182/blood-2005-05-2004] [Cited by in Crossref: 1693] [Cited by in F6Publishing: 1397] [Article Influence: 105.8] [Reference Citation Analysis]
31 Lee YG, Kim I, Kwon JH, Yoon SS, Park S, Song L, Yoon JH, Shin SH, Min WS, Kim HJ. Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia. Thromb Haemost 2015;113:201-8. [PMID: 25339605 DOI: 10.1160/TH13-12-1020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Noer MC, Sperling C, Christensen IJ, Nielsen ML, Lidegaard O, Høgdall C. Comorbidity is an independent prognostic factor in women with uterine corpus cancer: a nationwide cohort study. Acta Obstet Gynecol Scand 2014;93:325-34. [PMID: 24443826 DOI: 10.1111/aogs.12338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Fields PA, Linch DC. Treatment of the elderly patient with diffuse large B cell lymphoma: Review. British Journal of Haematology 2012;157:159-70. [DOI: 10.1111/j.1365-2141.2011.09011.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
34 Salako O, Okediji PT, Habeebu MY, Fatiregun OA, Awofeso OM, Okunade KS, Odeniyi IA, Salawu KO, Oboh EO. The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria. Ecancermedicalscience 2018;12:843. [PMID: 30034520 DOI: 10.3332/ecancer.2018.843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 2019;26:619-27. [PMID: 30324485 DOI: 10.1245/s10434-018-6807-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Skillington SA, Kallogjeri D, Lewis JS Jr, Piccirillo JF. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 2017;143:253-9. [PMID: 27918781 DOI: 10.1001/jamaoto.2016.3353] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
37 Pipkorn P, Licata J, Kallogjeri D, Piccirillo JF. Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 2018;144:738-45. [PMID: 30003215 DOI: 10.1001/jamaoto.2018.1230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer. 2007;43:2179-2193. [PMID: 17681780 DOI: 10.1016/j.ejca.2007.06.008] [Cited by in Crossref: 164] [Cited by in F6Publishing: 136] [Article Influence: 11.7] [Reference Citation Analysis]
39 Gould MK, Munoz-Plaza CE, Hahn EE, Lee JS, Parry C, Shen E. Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc 2017;14:1571-80. [PMID: 28541748 DOI: 10.1513/AnnalsATS.201701-030OC] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 8.3] [Reference Citation Analysis]
40 Lee CT, Mei M, Ashley J, Breslow G, O'donnell M, Gilbert S, Lemmy S, Saxton C, Sagalowsky A, Sansgiry S, Latini DM. Patient Resources Available to Bladder Cancer Patients: A Pilot Study of Healthcare Providers. Urology 2012;79:172-7. [DOI: 10.1016/j.urology.2011.07.1405] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
41 Zist A, Amir E, Ocana AF, Seruga B. Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel. Radiol Oncol 2015;49:402-8. [PMID: 26834528 DOI: 10.1515/raon-2015-0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
42 Hoeben KW, van Steenbergen LN, van de Wouw AJ, Rutten HJ, van Spronsen DJ, Janssen-Heijnen ML. Treatment and complications in elderly stage III colon cancer patients in the Netherlands. Ann Oncol. 2013;24:974-979. [PMID: 23136227 DOI: 10.1093/annonc/mds576] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
43 Fiacchini G, Tricò D, Ribechini A, Forfori F, Brogi E, Lucchi M, Berrettini S, Bertini P, Guarracino F, Bruschini L. Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg 2021;147:70-6. [PMID: 33211087 DOI: 10.1001/jamaoto.2020.4148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
44 Clément-Duchêne C, Stock S, Xu X, Chang ET, Gomez SL, West DW, Wakelee HA, Gould MK. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study. Ann Am Thorac Soc 2016;13:58-66. [PMID: 26730864 DOI: 10.1513/AnnalsATS.201504-241OC] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
45 Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol 2011;47:974-9. [PMID: 21856209 DOI: 10.1016/j.oraloncology.2011.07.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
46 Wei YF, Chen JY, Lee HS, Wu JT, Hsu CK, Hsu YC. Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study. BMJ Open 2018;8:e019661. [PMID: 29371286 DOI: 10.1136/bmjopen-2017-019661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
47 Sierakowski A, Nawar A, Parker M, Mathur B. Free flap surgery in the elderly: Experience with 110 cases aged ≥70 years. Journal of Plastic, Reconstructive & Aesthetic Surgery 2017;70:189-95. [DOI: 10.1016/j.bjps.2016.11.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
48 Shelby RA, Dorfman CS, Bosworth HB, Keefe F, Sutton L, Owen L, Corsino L, Erkanli A, Reed SD, Arthur SS, Somers T, Barrett N, Huettel S, Gonzalez JM, Kimmick G. Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET). Contemp Clin Trials 2019;76:120-31. [PMID: 30472215 DOI: 10.1016/j.cct.2018.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
49 Wong Doo N, Coory M, White V, Harrison SJ, Prince HM, Millar JL, Dimech M, Giles GG; IMPROVE Project. Low uptake of upfront autologous transplantation for myeloma in a jurisdiction with universal health care coverage: a population-based patterns of care study in Australia. Clin Lymphoma Myeloma Leuk 2014;14:61-7. [PMID: 24210724 DOI: 10.1016/j.clml.2013.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Yoon BC, Molina C, Gokaslan ZL, Sciubba DM. Metastatic spine disease in the elderly: diagnostic and management considerations. Aging Health 2011;7:607-17. [DOI: 10.2217/ahe.11.42] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54:1898-1904. [PMID: 17198496 DOI: 10.1111/j.1532-5415.2006.00973.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 7.6] [Reference Citation Analysis]
52 Stone RL, Sood AK, Coleman RL. Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer. Lancet Oncol 2010;11:465-75. [PMID: 20226736 DOI: 10.1016/S1470-2045(09)70362-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
53 Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Port ER, Morrow M, Gemignani ML. Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes. Ann Surg Oncol 2009;16:1952-8. [DOI: 10.1245/s10434-009-0440-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
54 van der Schroeff MP, Baatenburg de Jong RJ. Staging and prognosis in head and neck cancer. Oral Oncology 2009;45:356-60. [DOI: 10.1016/j.oraloncology.2008.05.022] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
55 Tian Y, Jian Z, Xu B, Liu H. Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection. Oncotarget. 2017;8:79453-79461. [PMID: 29108324 DOI: 10.18632/oncotarget.18401] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
56 Newberry KJ, Naqvi K, Nguyen KT, Cardenas-Turanzas M, Florencia Tanaka M, Pierce S, Verstovsek S. Comorbidities predict worse prognosis in patients with primary myelofibrosis. Cancer 2014;120:2996-3002. [PMID: 24917509 DOI: 10.1002/cncr.28857] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
57 Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 2012;23:2346-52. [PMID: 22357249 DOI: 10.1093/annonc/mds001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
58 Seruga B, Hertz P, Wang L, Booth C, Cescon D, Krzyzanowska M, Tannock I. Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer. Annals of Oncology 2010;21:1411-8. [DOI: 10.1093/annonc/mdp552] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
59 Wong ML, McMurry TL, Schumacher JR, Hu CY, Stukenborg GJ, Francescatti AB, Greenberg CC, Chang GJ, McKellar DP, Walter LC, Kozower BD. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03). J Oncol Pract 2018;14:e631-43. [PMID: 30207852 DOI: 10.1200/JOP.18.00175] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
60 Sindhar S, Kallogjeri D, Wildes TS, Avidan MS, Piccirillo JF. Association of Preoperative Functional Performance With Outcomes After Surgical Treatment of Head and Neck Cancer: A Clinical Severity Staging System. JAMA Otolaryngol Head Neck Surg 2019;145:1128-36. [PMID: 31045219 DOI: 10.1001/jamaoto.2019.1035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
61 Constantinou P, Dray-Spira R, Menvielle G. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey. BMC Cancer 2016;16:255. [PMID: 27029643 DOI: 10.1186/s12885-016-2295-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
62 Hines RB, Shanmugam C, Waterbor JW, McGwin G Jr, Funkhouser E, Coffey CS, Posey J, Manne U. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer 2009;115:5798-806. [PMID: 19937953 DOI: 10.1002/cncr.24598] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
63 Coindard G, Barrière J, Vega A, Patrikidou A, Saldanha-Gomes C, Arnould P, Combessie P, Ourabah R. What role does the general practitioner in France play among cancer patients during the initial treatment phase with intravenous chemotherapy? A qualitative study. Eur J Gen Pract 2016;22:96-102. [PMID: 26799829 DOI: 10.3109/13814788.2015.1126821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
64 Torres-Espíndola LM, Demetrio-Ríos J, Carmona-Aparicio L, Galván-Díaz C, Pérez-García M, Chávez-Pacheco JL, Granados-Montiel J, Torres-Ramírez de Arellano I, Aquino-Gálvez A, Castillejos-López MJ. Comorbidity Index as a Predictor of Mortality in Pediatric Patients With Solid Tumors. Front Pediatr 2019;7:48. [PMID: 30881949 DOI: 10.3389/fped.2019.00048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
65 Lekovic D, Gotic M, Sefer D, Mitrovic-Ajtic O, Cokic V, Milic N. Predictors of survival and cause of death in patients with essential thrombocythemia. Eur J Haematol 2015;95:461-6. [PMID: 25645731 DOI: 10.1111/ejh.12517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
66 Maas HA, Lemmens VE, Nijhuis PH, de Hingh IH, Koning CC, Janssen-Heijnen ML. Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older. Eur J Surg Oncol. 2013;39:1087-1093. [PMID: 23958151 DOI: 10.1016/j.ejso.2013.07.094] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
67 Tham T, Wotman M, Chung C, Ahn S, Dupuis H, Gliagias V, Movsesova T, Kraus D, Costantino P. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis. Eur Arch Otorhinolaryngol 2019;276:2913-22. [DOI: 10.1007/s00405-019-05554-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
68 Fiorica F, Berretta M, Ursino S, Fisichella R, Lleshi A, Fiorica G, Stefanelli A, Zini G, Tirelli U, Zanghi A, Cappellani A, Berretta S, Cartei F. Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: A retrospective analysis. Archives of Gerontology and Geriatrics 2012;55:283-8. [DOI: 10.1016/j.archger.2011.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
69 Terhaard CHJ, van der Schroeff MP, van Schie K, Eerenstein SEJ, Lubsen H, Kaanders JHAM, Smeele LE, Burlage FR, van Den Ende PL, Baatenburg de Jong RJ. The prognostic role of comorbidity in salivary gland carcinoma. Cancer 2008;113:1572-9. [DOI: 10.1002/cncr.23771] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
70 Jiramongkolchai P, Peterson A, Kallogjeri D, Lee JJ, Kukuljan S, Liebendorfer A, Schneider JS, Klatt‐cromwell CN, Drescher AJ, Piccirillo JF. Randomized clinical trial to evaluate mometasone lavage vs spray for patients with chronic rhinosinusitis without nasal polyps who have not undergone sinus surgery. Int Forum Allergy Rhinol 2020;10:936-43. [DOI: 10.1002/alr.22586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
71 Duffy SA, Khan MJ, Ronis DL, Fowler KE, Gruber SB, Wolf GT, Terrell JE. Health behaviors of head and neck cancer patients the first year after diagnosis. Head Neck 2008;30:93-102. [PMID: 17685451 DOI: 10.1002/hed.20665] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
72 Lee CC, Chang TS, Wu CJ, Yang CC, Chen PC. Determinants of End-of-Life Expenditures in Patients with Oral Cancer in Taiwan: A Population-Based Study. PLoS One 2015;10:e0126482. [PMID: 25946011 DOI: 10.1371/journal.pone.0126482] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Yano T, Shimokawa M, Kawashima O, Takenoyama M, Yamashita Y, Fukami T, Ueno T, Yatsuyanagi E, Fukuyama S; For the National Hospital Organization Network Collaborative Research—Thoracic Oncology Group. The influence of comorbidity on the postoperative survival in elderly (≥ 75 years old) with lung cancer. Gen Thorac Cardiovasc Surg 2018;66:344-50. [DOI: 10.1007/s11748-018-0919-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Blanco R, Maestu I, de la Torre MG, Cassinello A, Nuñez I. A review of the management of elderly patients with non-small-cell lung cancer. Ann Oncol 2015;26:451-63. [PMID: 25060421 DOI: 10.1093/annonc/mdu268] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
75 Chen DY, Uzzo RG, Viterbo R. Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death. World J Urol 2014;32:607-13. [PMID: 24710683 DOI: 10.1007/s00345-014-1285-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
76 Fanucchi O, Ambrogi MC, Dini P, Lucchi M, Melfi F, Davini F, Mussi A. Surgical treatment of non-small cell lung cancer in octogenarians. Interactive CardioVascular and Thoracic Surgery 2011;12:749-53. [DOI: 10.1510/icvts.2010.259002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
77 Froehner M, Koch R, Litz RJ, Haase M, Klenk U, Oehlschlaeger S, Baretton GB, Wirth MP. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy. Scand J Urol Nephrol 2005;39:449-54. [PMID: 16303719 DOI: 10.1080/00365590510031174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
78 Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol 2012;30:1447-55. [PMID: 22454424 DOI: 10.1200/JCO.2011.39.5269] [Cited by in Crossref: 104] [Cited by in F6Publishing: 39] [Article Influence: 11.6] [Reference Citation Analysis]
79 Miesfeldt S, Murray K, Lucas L, Chang CH, Goodman D, Morden NE. Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer. J Palliat Med 2012;15:548-54. [PMID: 22468739 DOI: 10.1089/jpm.2011.0310] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 8.8] [Reference Citation Analysis]
80 Marrie RA, Maxwell C, Mahar A, Ekuma O, McClintock C, Seitz D, Groome P. Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study. Neurology 2021;97:e13-22. [PMID: 34011575 DOI: 10.1212/WNL.0000000000012127] [Reference Citation Analysis]
81 Gadzinski AJ, Psutka SP. Risk stratification metrics for bladder cancer: Comprehensive Geriatric Assessments. Urol Oncol 2020;38:725-33. [PMID: 32037198 DOI: 10.1016/j.urolonc.2020.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
82 Walterbos NR, Fiocco M, Neelis KJ, van der Linden YM, Langers AMJ, Slingerland M, de Steur WO, Peters FP, Lips IM. Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer. Clin Transl Radiat Oncol 2019;17:24-31. [PMID: 31193091 DOI: 10.1016/j.ctro.2019.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
83 Hernandez Torres C, Hsu T. Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review. Eur Urol Focus 2017;3:330-9. [PMID: 29331624 DOI: 10.1016/j.euf.2017.10.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
84 Nanda A, Chen MH, Moran BJ, Braccioforte MH, D'Amico AV. Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy. Int J Radiat Oncol Biol Phys 2013;85:e209-15. [PMID: 23332383 DOI: 10.1016/j.ijrobp.2012.11.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
85 Aarstad HJ, Østhus AA, Aarstad HH, Lybak S, Aarstad AKH. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. Eur Arch Otorhinolaryngol 2018;275:207-17. [PMID: 29159750 DOI: 10.1007/s00405-017-4800-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
86 Frey C, Zhou H, Harvey D, White RH. Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis. J Gastrointest Surg. 2007;11:733-742. [PMID: 17417710 DOI: 10.1007/s11605-007-0164-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
87 Arthur AE, Peterson KE, Shen J, Djuric Z, Taylor JM, Hebert JR, Duffy SA, Peterson LA, Bellile EL, Whitfield JR, Chepeha DB, Schipper MJ, Wolf GT, Rozek LS. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma. Cancer 2014;120:2704-12. [PMID: 24830761 DOI: 10.1002/cncr.28778] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
88 Małyszko J, Małyszko M, Kozlowski L, Kozlowska K, Małyszko J. Hypertension in malignancy-an underappreciated problem. Oncotarget 2018;9:20855-71. [PMID: 29755695 DOI: 10.18632/oncotarget.25024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
89 Su C, Zhou F, Shen J, Zhao J, O'Brien M. Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced Non-Small Cell Lung Cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations - Still a daily challenge. Eur J Cancer 2017;83:266-78. [PMID: 28763691 DOI: 10.1016/j.ejca.2017.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
90 Tilki D, Chen MH, Wu J, Huland H, Graefen M, Braccioforte M, Moran BJ, D'Amico AV. Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality. JAMA Oncol 2019;5:213-20. [PMID: 30452521 DOI: 10.1001/jamaoncol.2018.4836] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
91 McDuff SGR, Chen MH, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV. Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer. Cancer 2018;124:1391-9. [PMID: 29338073 DOI: 10.1002/cncr.31217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
92 Posternak V, Dunn LB, Dhruva A, Paul SM, Luce J, Mastick J, Levine JD, Aouizerat BE, Hammer M, Wright F, Miaskowski C. Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain. Pain 2016;157:892-900. [PMID: 26683234 DOI: 10.1097/j.pain.0000000000000456] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
93 Dell’oglio P, Tian Z, Leyh-bannurah S, Larcher A, Mazzone E, Moschini M, Trudeau V, Stabile A, Gallina A, Suardi N, Capitanio U, Mottrie A, Briganti A, Montorsi F, Rochefort CM, Karakiewicz PI. Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy. Ann Surg Oncol 2019;26:1942-9. [DOI: 10.1245/s10434-019-07313-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
94 Jacobs DHM, Horeweg N, Straver M, Roeloffzen EMA, Speijer G, Merkus J, van der Sijp J, Mast ME, Fisscher U, Petoukhova AL, Zwanenburg AG, Marijnen CAM, Koper PCM. Health-related quality of life of breast cancer patients after accelerated partial breast irradiation using intraoperative or external beam radiotherapy technique. Breast 2019;46:32-9. [PMID: 31075670 DOI: 10.1016/j.breast.2019.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int 2012;110:201-5. [PMID: 22085233 DOI: 10.1111/j.1464-410X.2011.10709.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
96 Fleming ST, Mackley HB, Camacho F, Yao N, Gusani NJ, Seiber EE, Matthews SA, Yang TC, Hwang W. Patterns of Care for Metastatic Colorectal Cancer in Appalachia, and the Clinical, Sociodemographic, and Service Provider Determinants. J Rural Health 2016;32:113-24. [PMID: 26241785 DOI: 10.1111/jrh.12132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Lazovich D, Robien K, Cutler G, Virnig B, Sweeney C. Quality of life in a prospective cohort of elderly women with and without cancer. Cancer 2009;115:4283-97. [PMID: 19731348 DOI: 10.1002/cncr.24580] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
98 Simanek R, Walczuk J, Geissler K. Comorbidity – an important domain in elderly cancer patients' assessment. memo 2011;4:43-9. [DOI: 10.1007/s12254-011-0247-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Gien LT, Sutradhar R, Thomas G, Covens A, Elit L, Rakovitch E, Fyles A, Khalifa MA, Liu Y, Barbera L. Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: A population-based cohort study. Gynecologic Oncology 2015;139:465-70. [DOI: 10.1016/j.ygyno.2015.09.086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
100 Sanderson B, Mcwilliam A, Faivre-finn C, Kirkby NF, Jena R, Mee T, Choudhury A. Using the Malthus programme to predict the recruitment of patients to MR-linac research trials in prostate and lung cancer. Radiotherapy and Oncology 2017;122:159-62. [DOI: 10.1016/j.radonc.2016.11.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
101 Kallogjeri D, Gaynor SM, Piccirillo ML, Jean RA, Spitznagel EL Jr, Piccirillo JF. Comparison of comorbidity collection methods. J Am Coll Surg 2014;219:245-55. [PMID: 24933715 DOI: 10.1016/j.jamcollsurg.2014.01.059] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
102 Chen M, Liu X, Han C, Wang X, Zhao Y, Pang Q, Sun X, Li G, Zhang K, Li L, Qiao X, Lin Y, Chen J, Xiao Z. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A). BMC Cancer 2020;20:36. [PMID: 31941487 DOI: 10.1186/s12885-019-6461-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
103 Proctor SJ, Wilkinson J, Sieniawski M. Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future. Crit Rev Oncol Hematol 2009;71:222-32. [PMID: 19179093 DOI: 10.1016/j.critrevonc.2008.12.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
104 Grose D, Morrison DS, Devereux G, Jones R, Sharma D, Selby C, Docherty K, McIntosh D, Louden G, Nicolson M, McMillan DC, Milroy R; Scottish Lung Cancer Forum. Comorbidities in lung cancer: prevalence, severity and links with socioeconomic status and treatment. Postgrad Med J 2014;90:305-10. [PMID: 24676985 DOI: 10.1136/postgradmedj-2013-132186] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
105 Agaronnik ND, El-Jawahri A, Lindvall C, Iezzoni LI. Exploring the Process of Cancer Care for Patients With Pre-Existing Mobility Disability. JCO Oncol Pract 2021;17:e53-61. [PMID: 33351675 DOI: 10.1200/OP.20.00378] [Reference Citation Analysis]
106 Scailteux LM, Naudet F, Alimi Q, Vincendeau S, Oger E. Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer: A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies. Medicine (Baltimore) 2016;95:e3873. [PMID: 27310974 DOI: 10.1097/MD.0000000000003873] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
107 Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072-6082. [PMID: 16135474 DOI: 10.1200/jco.2005.08.104] [Cited by in Crossref: 129] [Cited by in F6Publishing: 39] [Article Influence: 8.1] [Reference Citation Analysis]
108 Alibhai SMH, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Is there an optimal comorbidity index for prostate cancer? Cancer 2008;112:1043-50. [DOI: 10.1002/cncr.23269] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
109 Skillington SA, Kallogjeri D, Lewis JS Jr, Piccirillo JF. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 2016;142:568-75. [PMID: 27077485 DOI: 10.1001/jamaoto.2016.0347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
110 Fisher DA, Zullig LL, Grambow SC, Abbott DH, Sandler RS, Fletcher RH, El-Serag HB, Provenzale D. Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci. 2010;55:1434-1441. [PMID: 20238248 DOI: 10.1007/s10620-010-1174-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
111 Tini G, Sarocchi M, Tocci G, Arboscello E, Ghigliotti G, Novo G, Brunelli C, Lenihan D, Volpe M, Spallarossa P. Arterial hypertension in cancer: The elephant in the room. Int J Cardiol 2019;281:133-9. [PMID: 30718135 DOI: 10.1016/j.ijcard.2019.01.082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
112 Klassen AC, Curriero F, Kulldorff M, Alberg AJ, Platz EA, Neloms ST. Missing stage and grade in Maryland prostate cancer surveillance data, 1992-1997. Am J Prev Med 2006;30:S77-87. [PMID: 16458794 DOI: 10.1016/j.amepre.2005.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
113 Martin NE, Chen MH, Beard CJ, Nguyen PL, Loffredo MJ, Renshaw AA, Kantoff PW, D'Amico AV. Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators. Prostate Cancer 2014;2014:912943. [PMID: 24701353 DOI: 10.1155/2014/912943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
114 Parikh S, Murray L, Kenning L, Bottomley D, Din O, Dixit S, Ferguson C, Handforth C, Joseph L, Mokhtar D, White L, Wright G, Henry A. Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer. Clinical Oncology 2018;30:548-55. [DOI: 10.1016/j.clon.2018.06.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
115 Tham T, Leung E, Olson C, Wotman M, Khaymovich J, Coury J, Teegala S, Costantino P. Evaluation of the prognostic utility of the combination of platelet count with mean platelet volume as a prognostic indicator in head and neck cancer. Mol Clin Oncol 2019;10:457-62. [PMID: 30931118 DOI: 10.3892/mco.2019.1813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Jain M, Townsend RR. Chemotherapy agents and hypertension: a focus on angiogenesis blockade. Curr Hypertens Rep 2007;9:320-8. [PMID: 17686384 DOI: 10.1007/s11906-007-0058-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
117 Sze HC, Ng W, Chan OS, Shum TC, Chan LL, Lee AW. Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: The importance of co-morbidity assessment. Oral Oncology 2012;48:162-7. [DOI: 10.1016/j.oraloncology.2011.08.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
118 Brewer N, Borman B, Sarfati D, Jeffreys M, Fleming ST, Cheng S, Pearce N. Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC Cancer 2011;11:132. [PMID: 21486460 DOI: 10.1186/1471-2407-11-132] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
119 Datema FR, Ferrier MB, Vergouwe Y, Moya A, Molenaar J, Piccirillo JF, Baatenburg de Jong RJ. Update and external validation of a head and neck cancer prognostic model. Head Neck 2013;35:1232-7. [DOI: 10.1002/hed.23117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
120 Marinello R, Marenco D, Roglia D, Stasi MF, Ferrando A, Ceccarelli M, Bertetto O, Molaschi M, Ciccone G. Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients. Archives of Gerontology and Geriatrics 2009;48:222-6. [DOI: 10.1016/j.archger.2008.01.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
121 Wachal B, Johnson M, Burchell A, Sayles H, Rieke K, Lindau R, Lydiatt W, Panwar A. Association of Modified Frailty Index Score With Perioperative Risk for Patients Undergoing Total Laryngectomy. JAMA Otolaryngol Head Neck Surg 2017;143:818-23. [PMID: 28594992 DOI: 10.1001/jamaoto.2017.0412] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
122 Clark JR, Mccluskey SA, Hall F, Lipa J, Neligan P, Brown D, Irish J, Gullane P, Gilbert R. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck 2007;29:1090-101. [DOI: 10.1002/hed.20639] [Cited by in Crossref: 151] [Cited by in F6Publishing: 119] [Article Influence: 10.8] [Reference Citation Analysis]
123 van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients. Circ Res 2021;128:1040-61. [PMID: 33793337 DOI: 10.1161/CIRCRESAHA.121.318051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Chaudhary RK, Bhaduri D, Bhatia M, Hatti S, Ba R, Meva J. Influence of comorbidity in cancer surgery on treatment decisions, postoperative course and oncological outcome: Effect of comorbidity in cancer surgery. Asia-Pac J Clin Oncol 2013;9:47-52. [DOI: 10.1111/j.1743-7563.2012.01523.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
125 Cazzola M, Della Porta MG, Travaglino E, Malcovati L. Classification and Prognostic Evaluation of Myelodysplastic Syndromes. Seminars in Oncology 2011;38:627-34. [DOI: 10.1053/j.seminoncol.2011.04.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
126 Tham T, Olson C, Wotman M, Teegala S, Khaymovich J, Coury J, Costantino P. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer. Eur Arch Otorhinolaryngol 2018;275:2869-78. [PMID: 30251123 DOI: 10.1007/s00405-018-5144-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
127 Rich JT, Liu J, Haughey BH. Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope 2011;121:2381-90. [PMID: 21882203 DOI: 10.1002/lary.21406] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
128 Mclarnon C, Kulloo P, Mehanna H, Kelly C, Paleri V. Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer. Expert Review of Anticancer Therapy 2014;10:345-52. [DOI: 10.1586/era.10.13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
129 Aldawood AS. Prognosis and Resuscitation Status of Critically Ill Patients with Lung Cancer Admitted to the Intensive Care Unit. Anaesth Intensive Care 2010;38:920-3. [DOI: 10.1177/0310057x1003800517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
130 Konety BR. Sickness and Survival in Bladder Cancer: Is Comorbidity the Crystal Ball? European Urology 2008;53:465-7. [DOI: 10.1016/j.eururo.2007.11.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
131 Wu IC, Lin CC, Hsiung CA. Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. Biomedicine (Taipei) 2015;5:1. [PMID: 25722960 DOI: 10.7603/s40681-015-0001-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
132 Lango MN, Egleston B, Fang C, Burtness B, Galloway T, Liu J, Mehra R, Ebersole B, Moran K, Ridge JA. Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer. Cancer. 2014;120:840-847. [PMID: 24352973 DOI: 10.1002/cncr.28482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
133 Ichikawa H, Kosugi SI, Kanda T, Yajima K, Ishikawa T, Hanyu T, Muneoka Y, Otani T, Nagahashi M, Sakata J, Kobayashi T, Kameyama H, Wakai T. Surgical and long-term outcomes following oesophagectomy in oesophageal cancer patients with comorbidity. Int J Surg 2016;36:212-8. [PMID: 27810380 DOI: 10.1016/j.ijsu.2016.10.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
134 Unger JM, Hershman DL, Fleury ME, Vaidya R. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation. JAMA Oncol 2019;5:326-33. [PMID: 30629092 DOI: 10.1001/jamaoncol.2018.5953] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 23.0] [Reference Citation Analysis]
135 Freeman SC, Satish M, Walters RW. Comorbidity burden on receipt of adjuvant immunotherapy and survival in patients with stage III melanoma: an analysis of the National Cancer Database. Int J Dermatol 2020;59:1381-90. [PMID: 32592609 DOI: 10.1111/ijd.15019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Yokosawa EB, Arthur AE, Rentschler KM, Wolf GT, Rozek LS, Mondul AM. Vitamin D intake and survival and recurrence in head and neck cancer patients. Laryngoscope 2018;128:E371-6. [PMID: 29756240 DOI: 10.1002/lary.27256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
137 Peters TT, Post SF, van Dijk BA, Roodenburg JL, van der Laan BF, Werker PM, Halmos GB. Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection. Eur Arch Otorhinolaryngol 2015;272:2999-3005. [PMID: 25217081 DOI: 10.1007/s00405-014-3268-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
138 Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. The Laryngoscope 2012;122:S13-33. [DOI: 10.1002/lary.23493] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 11.9] [Reference Citation Analysis]
139 Alfano CM, Cheville AL, Mustian K. Developing High-Quality Cancer Rehabilitation Programs: A Timely Need. Am Soc Clin Oncol Educ Book 2016;35:241-9. [PMID: 27249704 DOI: 10.1200/EDBK_156164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
140 Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection. J Gastrointest Surg 2020;24:368-79. [PMID: 30820801 DOI: 10.1007/s11605-019-04126-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
141 Megwalu II, Vlahiotis A, Radwan M, Piccirillo JF, Kibel AS. Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol 2008;53:581-9. [PMID: 17997024 DOI: 10.1016/j.eururo.2007.10.069] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
142 Velasco E, Portugal RD, Salluh JI. A simple score to predict early death in adult cancer patients with bloodstream infections. Journal of Infection 2009;59:332-6. [DOI: 10.1016/j.jinf.2009.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
143 Milne S, Parmar J, Ong T. Adult Comorbidity Evaluation-27 as a predictor of postoperative complications, two-year mortality, duration of hospital stay, and readmission within 30 days in patients with squamous cell carcinoma of the head and neck. British Journal of Oral and Maxillofacial Surgery 2019;57:214-8. [DOI: 10.1016/j.bjoms.2019.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
144 DE Felice F, Galdieri A, Abate G, Bulzonetti N, Musio D, Tombolini V. Definitive Intensity-modulated Radiation Therapy in Elderly Patients with Locally Advanced Oropharyngeal Cancer. In Vivo 2017;31:455-9. [PMID: 28438879 DOI: 10.21873/invivo.11083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
145 van Nieuwenhuizen AJ, Buffart LM, Langendijk JA, Vergeer MR, Voortman J, Leemans CR, Verdonck-de Leeuw IM. Health-related quality of life and overall survival: a prospective study in patients with head and neck cancer treated with radiotherapy. Qual Life Res 2021;30:1145-53. [PMID: 33289866 DOI: 10.1007/s11136-020-02716-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
146 Shelby RA, Dorfman CS, Arthur SS, Bosworth HB, Corsino L, Sutton L, Owen L, Erkanli A, Keefe F, Corbett C, Kimmick G. Improving health engagement and lifestyle management for breast cancer survivors with diabetes. Contemp Clin Trials 2020;92:105998. [PMID: 32289471 DOI: 10.1016/j.cct.2020.105998] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Sullivan DR, Ganzini L, Duckart JP, Lopez-Chavez A, Deffebach ME, Thielke SM, Slatore CG. Treatment receipt and outcomes among lung cancer patients with depression. Clin Oncol (R Coll Radiol) 2014;26:25-31. [PMID: 24080122 DOI: 10.1016/j.clon.2013.09.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
148 Amini A, McDermott JD, Gan G, Bhatia S, Sumner W, Fisher CM, Jimeno A, Bowles DW, Raben D, Karam SD. Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance. Front Oncol 2014;4:274. [PMID: 25340041 DOI: 10.3389/fonc.2014.00274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
149 Hurria A, Browner IS, Cohen HJ, Denlinger CS, deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB, Keating NL, McKoy J, Medeiros BC, Mrozek E, O'Connor T, Petersdorf SH, Rugo HS, Silliman RA, Tew WP, Walter LC, Weir AB 3rd, Wildes T. Senior adult oncology. J Natl Compr Canc Netw 2012;10:162-209. [PMID: 22308515 DOI: 10.6004/jnccn.2012.0019] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 8.2] [Reference Citation Analysis]
150 van Ruler MAP, Peters FP, Slingerland M, Fiocco M, Grootenboers DARH, Vulink AJE, Marijnen CAM, Neelis KJ. Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer. Diseases of the Esophagus 2017;30:1-9. [DOI: 10.1093/dote/dow033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
151 Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24:3527-3534. [PMID: 16822844 DOI: 10.1200/jco.2006.06.0855] [Cited by in Crossref: 556] [Cited by in F6Publishing: 261] [Article Influence: 37.1] [Reference Citation Analysis]
152 Hall SF, Griffiths RJ, O'Sullivan B, Liu FF. The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting. Head Neck 2019;41:2271-6. [PMID: 30719797 DOI: 10.1002/hed.25679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Bøje CR. Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma – A systematic review. Radiotherapy and Oncology 2014;110:81-90. [DOI: 10.1016/j.radonc.2013.07.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 7.9] [Reference Citation Analysis]
154 Cardwell CR, Mc Menamin ÚC, Hicks BM, Hughes C, Cantwell MM, Murray LJ. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts. BMC Med. 2014;12:28. [PMID: 24521426 DOI: 10.1186/1741-7015-12-28] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
155 Nguyen PL, Chen M, Renshaw AA, Loffredo M, Kantoff PW, D'amico AV. Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations. International Journal of Radiation Oncology*Biology*Physics 2010;76:337-41. [DOI: 10.1016/j.ijrobp.2009.01.045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
156 Ahn DW, Lee SH, Kim J, Yoon WJ, Hwang JH, Jang JY, Ryu JK, Kim YT, Kim SW, Yoon YB. Long-term outcome of cystic lesions in the pancreas: a retrospective cohort study. Gut Liver 2012;6:493-500. [PMID: 23170156 DOI: 10.5009/gnl.2012.6.4.493] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
157 Peterson AM, Lee JJ, Kallogjeri D, Schneider JS, Chakinala MM, Piccirillo JF. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2020;146:1006-14. [PMID: 32940653 DOI: 10.1001/jamaoto.2020.3025] [Reference Citation Analysis]
158 Sinha P, Lewis JS, Piccirillo JF, Kallogjeri D, Haughey BH. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma: Extracapsular Spread in p16+ OPSCC. Cancer 2012;118:3519-30. [DOI: 10.1002/cncr.26671] [Cited by in Crossref: 175] [Cited by in F6Publishing: 153] [Article Influence: 17.5] [Reference Citation Analysis]
159 Wo JY, Chen MH, Nguyen PL, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV. Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence. J Clin Oncol 2009;27:6000-5. [PMID: 19858385 DOI: 10.1200/JCO.2009.23.6067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
160 Nguyen PL, Chen M, Beard CJ, Suh WW, Renshaw AA, Loffredo M, Mcmahon E, Kantoff PW, D'amico AV. Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization Analysis by Risk Group. International Journal of Radiation Oncology*Biology*Physics 2010;77:1046-52. [DOI: 10.1016/j.ijrobp.2009.06.038] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
161 Ahmed T, Lycan T, Dothard A, Ehrlichman P, Ruiz J, Farris M, Topaloglu U, Levine B, Grant S, Klepin HD, Petty WJ. Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer 2020;21:e286-93. [PMID: 32089478 DOI: 10.1016/j.cllc.2020.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
162 Sprave T, Rühle A, Stoian R, Weber A, Zamboglou C, Nieder C, Grosu AL, Nicolay NH. Radiotherapy for nonagenarians: the value of biological versus chronological age. Radiat Oncol 2020;15:113. [PMID: 32430009 DOI: 10.1186/s13014-020-01563-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
163 Lee JJ, Roland LT, Licata JJ, Orlowski HLP, Jiramongkolchai P, Piccirillo JF, Kallogjeri D, Klatt-Cromwell CN, Chernock RD, Schneider JS. Morphologic, intraoperative, and histologic risk factors for sinonasal inverted papilloma recurrence. Laryngoscope 2020;130:590-6. [PMID: 31112326 DOI: 10.1002/lary.28078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
164 Laribi K, Sobh M, Ghez D, Baugier de Materre A. Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review. Ann Hematol 2021;100:1359-76. [PMID: 33796898 DOI: 10.1007/s00277-020-04375-x] [Reference Citation Analysis]
165 Keating NL, Huskamp HA, Kouri E, Schrag D, Hornbrook MC, Haggstrom DA, Landrum MB. Factors Contributing To Geographic Variation In End-Of-Life Expenditures For Cancer Patients. Health Aff (Millwood) 2018;37:1136-43. [PMID: 29985699 DOI: 10.1377/hlthaff.2018.0015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
166 Cotter SE, Chen MH, Moul JW, Lee WR, Koontz BF, Anscher MS, Robertson CN, Walther PJ, Polascik TJ, D'amico AV. Salvage radiation in men after prostate-specific antigen failure and the risk of death. Cancer 2011;117:3925-32. [DOI: 10.1002/cncr.25993] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 7.7] [Reference Citation Analysis]
167 Rowland JH. Survivorship Research: Past, Present, and Future. In: Ganz PA, editor. Cancer Survivorship. New York: Springer; 2007. pp. 28-42. [DOI: 10.1007/978-0-387-68265-5_4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
168 Chung R, Tyebally S, Chen D, Kapil V, Walker JM, Addison D, Ismail-Khan R, Guha A, Ghosh AK. Hypertensive Cardiotoxicity in Cancer Treatment-Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies-Epidemiology, Incidence, and Pathophysiology. J Clin Med 2020;9:E3346. [PMID: 33081013 DOI: 10.3390/jcm9103346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Royce TJ, Chen MH, Wu J, Loffredo M, Renshaw AA, Kantoff PW, D'Amico AV. Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 2017;3:652-8. [PMID: 28097317 DOI: 10.1001/jamaoncol.2016.5983] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
170 Trask PC, Blank TO, Jacobsen PB. Future perspectives on the treatment issues associated with cancer and aging. Cancer 2008;113:3512-8. [PMID: 19058146 DOI: 10.1002/cncr.23940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
171 Rogers SN, Aziz A, Lowe D, Husband DJ. Feasibility study of the retrospective use of the Adult Comorbidity Evaluation index (ACE-27) in patients with cancer of the head and neck who had radiotherapy. British Journal of Oral and Maxillofacial Surgery 2006;44:283-8. [DOI: 10.1016/j.bjoms.2005.06.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
172 Tait S, Kallogjeri D, Suko J, Kukuljan S, Schneider J, Piccirillo JF. Effect of Budesonide Added to Large-Volume, Low-pressure Saline Sinus Irrigation for Chronic Rhinosinusitis: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2018;144:605-12. [PMID: 29879268 DOI: 10.1001/jamaoto.2018.0667] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
173 Eichhorst B, Goede V, Hallek M. Treatment of elderly patients with chronic lymphocytic leukemia. Leuk Lymphoma 2009;50:171-8. [PMID: 19197731 DOI: 10.1080/10428190802688517] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
174 Lee AR, Seo MJ, Kim J, Lee DM, Kim IY, Yoon MJ, Hoon H, Choi KS. Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca2+ Overload. Int J Mol Sci 2019;20:E6112. [PMID: 31817163 DOI: 10.3390/ijms20246112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Mercurio V, Cuomo A, Cadeddu Dessalvi C, Deidda M, Di Lisi D, Novo G, Manganaro R, Zito C, Santoro C, Ameri P, Spallarossa P, Arboscello E, Tocchetti CG, Penna C. Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC). Antioxidants (Basel) 2020;9:E641. [PMID: 32708201 DOI: 10.3390/antiox9070641] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
176 Sattar S, Alibhai SM, Wildiers H, Puts MT. How to implement a geriatric assessment in your clinical practice. Oncologist 2014;19:1056-68. [PMID: 25187477 DOI: 10.1634/theoncologist.2014-0180] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
177 Tournigand C, André T, Bonnetain F, Chibaudel B, Lledo G, Hickish T, Tabernero J, Boni C, Bachet JB, Teixeira L. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol. 2012;30:3353-3360. [PMID: 22915656 DOI: 10.1200/jco.2012.42.5645] [Cited by in Crossref: 228] [Cited by in F6Publishing: 79] [Article Influence: 25.3] [Reference Citation Analysis]
178 Salas M, Henderson M, Sundararajan M, Tu N, Islam Z, Ebeid M, Horne L. Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review. PLoS One 2021;16:e0252925. [PMID: 34143813 DOI: 10.1371/journal.pone.0252925] [Reference Citation Analysis]
179 Sarris EG, Harrington KJ, Saif MW, Syrigos KN. Multimodal treatment strategies for elderly patients with head and neck cancer. Cancer Treatment Reviews 2014;40:465-75. [DOI: 10.1016/j.ctrv.2013.10.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
180 Chhoda A, Yousaf MN, Madhani K, Aslanian H, Jamidar PA, Suarez AL, Salem RR, Muniraj T, Kunstman JW, Farrell JJ. Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31665-7. [PMID: 33309984 DOI: 10.1016/j.cgh.2020.12.008] [Reference Citation Analysis]
181 Vitzthum LK, Feng CH, Noticewala S, Hines PJ, Nguyen C, Zakeri K, Sojourner EJ, Shen H, Mell LK. Comparison of Comorbidity and Frailty Indices in Patients With Head and Neck Cancer Using an Online Tool. JCO Clin Cancer Inform 2018;2:1-9. [PMID: 30652602 DOI: 10.1200/CCI.18.00082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
182 Jackson RS, Chen S, Last A, Khan A, Kallogjeri D, Van Abel KM, Moore EJ, Pipkorn P. Multi-institutional analysis of outcomes following transoral surgery for HPV-positive oropharyngeal squamous cell carcinoma in elderly patients. Head Neck 2019;41:3933-9. [PMID: 31460691 DOI: 10.1002/hed.25946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
183 Espenel S, Garcia MA, Trone JC, Guillaume E, Harris A, Rehailia-Blanchard A, He MY, Ouni S, Vallard A, Rancoule C, Ben Mrad M, Chauleur C, De Laroche G, Guy JB, Moreno-Acosta P, Magné N. From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience. Radiat Oncol 2018;13:16. [PMID: 29394940 DOI: 10.1186/s13014-018-0963-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
184 Townsend M, Liou T, Kallogjeri D, Schoer M, Scott-Wittenborn N, Lindburg M, Bottros M, Jackson RS, Nussenbaum B, Piccirillo JF. Effect of Perioperative Gabapentin Use on Postsurgical Pain in Patients Undergoing Head and Neck Mucosal Surgery: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2018;144:959-66. [PMID: 29710075 DOI: 10.1001/jamaoto.2018.0282] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
185 Desai PB, Bukatko AR, Simpson MC, Adjei Boakye E, Greenberg JW, Ward GM, Walker RJ, Antisdel JL, Osazuwa Peters N. Comorbidity burden and nonclinical factors associated with sinonasal cancer all‐cause mortality. The Laryngoscope 2020;130:1443-9. [DOI: 10.1002/lary.28223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Laor A, Tal S, Guller V, Zbar AP, Mavor E. The Charlson Comorbidity Index (CCI) as a Mortality Predictor after Surgery in Elderly Patients. The American Surgeon 2016;82:22-7. [DOI: 10.1177/000313481608200113] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
187 Naqvi K, Garcia-Manero G, Sardesai S, Oh J, Vigil CE, Pierce S, Lei X, Shan J, Kantarjian HM, Suarez-Almazor ME. Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model. J Clin Oncol 2011;29:2240-6. [PMID: 21537048 DOI: 10.1200/JCO.2010.31.3353] [Cited by in Crossref: 100] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
188 He LR, Qiao W, Liao ZX, Komaki R, Ho L, Hofstetter WL, Lin SH. Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer 2015;15:1095. [PMID: 25777421 DOI: 10.1186/s12885-015-1095-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
189 Cohen M, Reuben D, Naeim A. Assessing the Older Cancer Patient. In: Hurria A, Balducci L, editors. Geriatric Oncology. Boston: Springer US; 2009. pp. 17-45. [DOI: 10.1007/978-0-387-89070-8_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
190 Park JW, Koh DH, Jang WS, Lee JY, Cho KS, Ham WS, Rha KH, Jung WH, Hong SJ, Choi YD. Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients. PLoS One 2018;13:e0199365. [PMID: 29924851 DOI: 10.1371/journal.pone.0199365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
191 Montero-Miranda PH, Ganly I. Survivorship--competing mortalities, morbidities, and second malignancies. Otolaryngol Clin North Am 2013;46:681-710. [PMID: 23910478 DOI: 10.1016/j.otc.2013.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
192 Deshields TL, Potter P, Olsen S, Liu J, Dye L. Documenting the symptom experience of cancer patients. J Support Oncol 2011;9:216-23. [PMID: 22055891 DOI: 10.1016/j.suponc.2011.06.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
193 Reed SC, Partridge AH, Nekhlyudov L. Shared Medical Appointments in Cancer Survivorship Care: A Review of the Literature. J Oncol Pract 2015;11:6-11. [PMID: 25424650 DOI: 10.1200/JOP.2014.001411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
194 van Leersum NJ, Janssen-Heijnen ML, Wouters MW, Rutten HJ, Coebergh JW, Tollenaar RA, Lemmens VE. Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995-2010. Int J Cancer 2013;132:2157-63. [PMID: 23015513 DOI: 10.1002/ijc.27871] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
195 Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol 2016;215:766.e1-9. [PMID: 27457116 DOI: 10.1016/j.ajog.2016.07.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
196 Lee YG, Lee JH, Kim SH, Kim YJ, Lee H, Ahn S, Jang JS, Lee JS, Kim JH. Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study. Lung Cancer 2018;122:88-93. [PMID: 30032852 DOI: 10.1016/j.lungcan.2018.05.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
197 Potosky AL, Malin JL, Kim B, Chrischilles EA, Makgoeng SB, Howlader N, Weeks JC. Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst 2011;103:979-82. [PMID: 21670423 DOI: 10.1093/jnci/djr152] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
198 Margalit DN, Mamon HJ, Ancukiewicz M, Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG, Hong TS. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys. 2011;81:e735-e741. [PMID: 21377289 DOI: 10.1016/j.ijrobp.2010.12.056] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
199 Daver N, Naqvi K, Jabbour E, Kadia T, DiNardo C, Cardenas-Turanzas M, Pierce S, Nguyen KT, Bueso-Ramos C, Kantarjian H, Garcia-Manero G. Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes. Am J Hematol 2014;89:509-16. [PMID: 24458781 DOI: 10.1002/ajh.23675] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
200 Borggreven PA, Kuik DJ, Langendijk JA, Doornaert P, de Bree R, Leemans CR. Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction. Oral Oncol 2005;41:358-64. [PMID: 15792607 DOI: 10.1016/j.oraloncology.2004.08.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
201 Ellin F, Jerkeman M, Törnqvist J, Brudin L, Relander T. Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study. Hematol Oncol 2018;36:159-65. [PMID: 28474339 DOI: 10.1002/hon.2428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
202 Millgård M, Tuomi L. Voice Quality in Laryngeal Cancer Patients: A Randomized Controlled Study of the Effect of Voice Rehabilitation. J Voice 2020;34:486.e13-22. [PMID: 32389236 DOI: 10.1016/j.jvoice.2018.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Fulton AJ, Lamarca A, Nuttall C, McCallum L, Pihlak R, O'Reilly D, Lalloo F, McNamara MG, Hubner RA, Clancy T, Valle JW. Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice. World J Gastrointest Oncol 2019;11:102-16. [PMID: 30788038 DOI: 10.4251/wjgo.v11.i2.102] [Reference Citation Analysis]
204 van Nieuwenhuizen AJ, Buffart LM, van Uden-Kraan CF, van der Velden LA, Lacko M, Brug J, Leemans CR, Verdonck-de Leeuw IM. Patient-reported physical activity and the association with health-related quality of life in head and neck cancer survivors. Support Care Cancer 2018;26:1087-95. [PMID: 29164375 DOI: 10.1007/s00520-017-3926-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
205 Dall'Era MA, Lo MJ, Chen J, Cress R, Hamilton AS. Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer. Cancer 2018;124:1921-8. [PMID: 29499075 DOI: 10.1002/cncr.31285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
206 Janz TA, Kim J, Hill EG, Sterba K, Warren G, Sharma AK, Day TA, Hughes-Halbert C, Graboyes EM. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 2018;144:1105-14. [PMID: 30347012 DOI: 10.1001/jamaoto.2018.2225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
207 Yusuf SW, Ilias-khan NA, Durand J. Chemotherapy-induced cardiomyopathy. Expert Review of Cardiovascular Therapy 2014;9:231-43. [DOI: 10.1586/erc.10.188] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
208 Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, Imbert Y, Cany L, Vogt L, Dauba J, Andriamampionona F, Houédé N, Floquet A, Chomy F, Brouste V, Ravaud A, Bellera C, Rainfray M. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012;30:1829-34. [PMID: 22508806 DOI: 10.1200/JCO.2011.35.7442] [Cited by in Crossref: 287] [Cited by in F6Publishing: 98] [Article Influence: 31.9] [Reference Citation Analysis]
209 Brunello A, Sandri R, Extermann M. Multidimensional geriatric evaluation for older cancer patients as a clinical and research tool. Cancer Treatment Reviews 2009;35:487-92. [DOI: 10.1016/j.ctrv.2009.04.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
210 Zhang Y, Yi J, Huang X, Xu G, Xiao J, Li S, Luo J, Zhang S, Wang K, Qu Y, Gao L. Inherently poor survival of elderly patients with nasopharyngeal carcinoma: Radiotherapy for Elderly Patients with NPC. Head Neck 2015;37:771-6. [DOI: 10.1002/hed.23497] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
211 Choi Y, Kim S, Yoon DH, Kim JY, Lee S, Cho K. Clinical Characteristics and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck: Adenoid Cystic Carcinoma of the Head and Neck. The Laryngoscope 2013;123:1430-8. [DOI: 10.1002/lary.23976] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
212 Schuette A, Lander DP, Kallogjeri D, Collopy C, Goddu S, Wildes TM, Daly M, Piccirillo JF. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 2020;146:106-12. [PMID: 31750863 DOI: 10.1001/jamaoto.2019.3550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
213 Chou WC, Chang PH, Lu CH, Liu KH, Hung YS, Hung CY, Liu CT, Yeh KY, Lin YC, Yeh TS. Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer 2016;7:854-61. [PMID: 27162545 DOI: 10.7150/jca.14777] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
214 McCowan C, Thompson AM. The importance of nonpharmacogenetic factors in endocrine therapy. Pharmacogenomics 2012;13:721-8. [PMID: 22515614 DOI: 10.2217/pgs.12.29] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
215 Galli A, Colombo M, Carrara G, Lira Luce F, Paesano PL, Giordano L, Bondi S, Tulli M, Mirabile A, De Cobelli F, Bussi M. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle. Eur Arch Otorhinolaryngol 2020;277:3489-502. [PMID: 32535862 DOI: 10.1007/s00405-020-06123-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ, Detterbeck FC, Kim AW. Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base. J Thorac Oncol 2016;11:1121-31. [PMID: 27103511 DOI: 10.1016/j.jtho.2016.03.023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
217 Khare SR, Batist G, Bartlett G. Identification of performance indicators across a network of clinical cancer programs. Curr Oncol 2016;23:81-90. [PMID: 27122972 DOI: 10.3747/co.23.2789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
218 Hovaldt HB, Suppli NP, Olsen MH, Steding-Jessen M, Hansen DG, Møller H, Johansen C, Dalton SO. Who are the cancer survivors? A nationwide study in Denmark, 1943-2010. Br J Cancer 2015;112:1549-53. [PMID: 25719832 DOI: 10.1038/bjc.2015.68] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
219 Patel SA, Chen M, Loffredo M, Renshaw A, Kantoff PW, D'amico AV. The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer. Prostate Cancer Prostatic Dis 2017;20:234-40. [DOI: 10.1038/pcan.2016.74] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
220 Genther DJ, Gourin CG. Effect of comorbidity on short-term outcomes and cost of care after head and neck cancer surgery in the elderly. Head Neck 2015;37:685-93. [PMID: 24596299 DOI: 10.1002/hed.23651] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
221 Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg. 2019;218:145-150. [PMID: 30224070 DOI: 10.1016/j.amjsurg.2018.08.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Sommat K, Yit NLF, Wang F, Lim JHC. Impact of comorbidity on tolerability and survival following curative intent intensity modulated radiotherapy in older patients with nasopharyngeal cancer. Journal of Geriatric Oncology 2018;9:352-8. [DOI: 10.1016/j.jgo.2018.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
223 Ngo-Huang A, Parker NH, Wang X, Petzel MQB, Fogelman D, Schadler KL, Bruera E, Fleming JB, Lee JE, Katz MHG. Home-based exercise during preoperative therapy for pancreatic cancer. Langenbecks Arch Surg 2017;402:1175-85. [PMID: 28710540 DOI: 10.1007/s00423-017-1599-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
224 Maitland ML, Bakris GL, Black HR, Chen HX, Durand JB, Elliott WJ, Ivy SP, Leier CV, Lindenfeld J, Liu G, Remick SC, Steingart R, Tang WH; Cardiovascular Toxicities Panel, Convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Drug Steering Committee. Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors. J Natl Cancer Inst 2010;102:596-604. [PMID: 20351338 DOI: 10.1093/jnci/djq091] [Cited by in Crossref: 281] [Cited by in F6Publishing: 211] [Article Influence: 25.5] [Reference Citation Analysis]
225 Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010;74:1041-7. [PMID: 20350978 DOI: 10.1212/WNL.0b013e3181d6b125] [Cited by in Crossref: 237] [Cited by in F6Publishing: 90] [Article Influence: 21.5] [Reference Citation Analysis]
226 Zhang S, Ivy JS, Payton FC, Diehl KM. Modeling the impact of comorbidity on breast cancer patient outcomes. Health Care Manag Sci 2010;13:137-54. [PMID: 20629416 DOI: 10.1007/s10729-009-9119-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
227 Morishima T, Matsumoto Y, Koeda N, Shimada H, Maruhama T, Matsuki D, Nakata K, Ito Y, Tabuchi T, Miyashiro I. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients. J Epidemiol 2019;29:110-5. [PMID: 30012908 DOI: 10.2188/jea.JE20170241] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 9.3] [Reference Citation Analysis]
228 Fernández-Ruiz M, Guerra-Vales JM, Colina-Ruizdelgado F. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol 2009;15:5279-86. [PMID: 19908335 DOI: 10.3748/wjg.15.5279] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
229 Xin G, Ruohoalho J, Bäck L, Aro K, Tapiovaara L. Analysis of 255 tracheostomies in an otorhinolaryngology-head and neck surgery tertiary care center: a safe procedure with a wide spectrum of indications. Eur Arch Otorhinolaryngol 2019;276:2069-73. [PMID: 31093734 DOI: 10.1007/s00405-019-05466-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
230 Caspers CJI, Dronkers EAC, Monserez D, Wieringa MH, Baatenburg de Jong RJ, Hardillo JAU. Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis. Clin Otolaryngol 2018;43:617-23. [PMID: 29150980 DOI: 10.1111/coa.13033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
231 Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness A. Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000. Head Neck 2019;41:1053-62. [PMID: 30549147 DOI: 10.1002/hed.25543] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
232 King LA, Priest KC, Nutt J, Chen Y, Chen Z, Melnick M, Horak F. Comorbidity and functional mobility in persons with Parkinson disease. Arch Phys Med Rehabil 2014;95:2152-7. [PMID: 25102383 DOI: 10.1016/j.apmr.2014.07.396] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
233 Hajjar LA, Costa IBSDSD, Lopes MACQ, Hoff PMG, Diz MDPE, Fonseca SMR, Bittar CS, Rehder MHHDS, Rizk SI, Almeida DR, Fernandes GDS, Beck-da-Silva L, Campos CAHM, Montera MW, Alves SMM, Fukushima JT, Santos MVCD, Negrão CE, Silva TLFD, Ferreira SMA, Malachias MVB, Moreira MDCV, Valente Neto MMR, Fonseca VCQ, Soeiro MCFA, Alves JBS, Silva CMPDC, Sbano J, Pavanello R, Pinto IMF, Simão AF, Dracoulakis MDA, Hoff AO, Assunção BMBL, Novis Y, Testa L, Alencar Filho AC, Cruz CBBV, Pereira J, Garcia DR, Nomura CH, Rochitte CE, Macedo AVS, Marcatti PTF, Mathias Junior W, Wiermann EG, Val RD, Freitas H, Coutinho A, Mathias CMC, Vieira FMAC, Sasse AD, Rocha V, Ramires JAF, Kalil Filho R. Brazilian Cardio-oncology Guideline - 2020. Arq Bras Cardiol 2020;115:1006-43. [PMID: 33295473 DOI: 10.36660/abc.20201006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Luque-Fernandez MA, Redondo-Sanchez D, Lee SF, Rodríguez-Barranco M, Carmona-García MC, Marcos-Gragera R, Sánchez MJ. Multimorbidity by Patient and Tumor Factors and Time-to-Surgery Among Colorectal Cancer Patients in Spain: A Population-Based Study. Clin Epidemiol 2020;12:31-40. [PMID: 32021469 DOI: 10.2147/CLEP.S229935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
235 Wen YF, Sun XS, Yuan L, Zeng LS, Guo SS, Liu LT, Lin C, Xie HJ, Liu SL, Li XY, Zhang YB, Huang WJ, Peng HH, Liao ZW, Song XL, Tang QN, Liang YJ, Yan JJ, Yang JH, Yang ZC, Chen QY, Lin XD, Tang LQ, Mai HQ. The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis. J Cancer 2019;10:5614-21. [PMID: 31737097 DOI: 10.7150/jca.35311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Grose D, Devereux G, Milroy R. Comorbidity in Lung Cancer: Important but Neglected. A Review of the Current Literature. Clinical Lung Cancer 2011;12:207-11. [DOI: 10.1016/j.cllc.2011.03.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
237 Pallis A, Wedding U, Lacombe D, Soubeyran P, Wildiers H. Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know? European Journal of Cancer 2010;46:1019-25. [DOI: 10.1016/j.ejca.2010.01.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
238 Hall SF, Groome PA, Irish J, O'Sullivan B. Towards further understanding of prognostic factors for head and neck cancer patients: the example of hypopharyngeal cancer. Laryngoscope 2009;119:696-702. [PMID: 19205009 DOI: 10.1002/lary.20112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
239 Kawakubo K, Tada M, Isayama H, Sasahira N, Nakai Y, Takahara N, Uchino R, Hamada T, Miyabayashi K, Yamamoto K, Mizuno S, Mohri D, Kogure H, Sasaki T, Yamamoto N, Hirano K, Ijichi H, Tateishi K, Koike K. Disease-Specific Mortality Among Patients With Intraductal Papillary Mucinous Neoplasm of the Pancreas. Clinical Gastroenterology and Hepatology 2014;12:486-91. [DOI: 10.1016/j.cgh.2013.06.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
240 Yan R, Xia J, Yang R, Lv B, Wu P, Chen W, Zhang Y, Lu X, Che B, Wang J, Yu J. Association between anxiety, depression, and comorbid chronic diseases among cancer survivors. Psychooncology 2019;28:1269-77. [PMID: 30946503 DOI: 10.1002/pon.5078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
241 Hussain M, Hou Y, Watson C, Moudgil R, Shah C, Abraham J, Budd GT, Tang WHW, Finet JE, James K, Estep JD, Xu B, Hu B, Cremer P, Jellis C, Grimm RA, Greenberg N, Popovic ZB, Cho L, Desai MY, Nissen SE, Kapadia SR, Svensson LG, Griffin BP, Cheng F, Collier P. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer. Am J Cardiol 2020;137:118-24. [PMID: 32991858 DOI: 10.1016/j.amjcard.2020.09.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
242 Seeger-Nukpezah T, Geynisman DM, Nikonova AS, Benzing T, Golemis EA. The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease. Nat Rev Nephrol 2015;11:515-34. [PMID: 25870008 DOI: 10.1038/nrneph.2015.46] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 11.7] [Reference Citation Analysis]
243 Nilsson J, Berglund A, Bergström S, Bergqvist M, Lambe M. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study. Acta Oncol 2017;56:949-56. [PMID: 28486004 DOI: 10.1080/0284186X.2017.1324213] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
244 Liu H, Chen QY, Guo L, Tang LQ, Mo HY, Zhong ZL, Huang PY, Luo DH, Sun R, Guo X, Cao KJ, Hong MH, Mai HQ. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis. Radiat Oncol 2013;8:70. [PMID: 23521779 DOI: 10.1186/1748-717X-8-70] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
245 Greene F. Perioperative Complications in the Cancer Patient: A Robust Prognostic Factor. Ann Surg Oncol 2013;20:4061-2. [DOI: 10.1245/s10434-013-3268-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Kuijpens JL, Janssen-Heijnen ML, Lemmens VE, Haak HR, Heijckmann AC, Coebergh JW. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival. Clin Endocrinol (Oxf) 2006;64:450-5. [PMID: 16584519 DOI: 10.1111/j.1365-2265.2006.02492.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
247 Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHG. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery 2018;164:424-31. [PMID: 29807648 DOI: 10.1016/j.surg.2018.04.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
248 Singh V, Yadav R, Sinha RJ, Gupta DK. Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model: Quality-of-life assessment after radical cystectomy. BJU Int 2014;113:726-32. [DOI: 10.1111/bju.12440] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
249 Ahove DA, Hoffman KE, Hu JC, Choueiri TK, D'amico AV, Nguyen PL. Which Patients With Undetectable PSA Levels 5 Years After Radical Prostatectomy Are Still at Risk of Recurrence?—Implications for a Risk-adapted Follow-up Strategy. Urology 2010;76:1201-5. [DOI: 10.1016/j.urology.2010.03.092] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
250 Parker NH, Ngo-Huang A, Lee RE, O'Connor DP, Basen-Engquist KM, Petzel MQB, Wang X, Xiao L, Fogelman DR, Schadler KL, Simpson RJ, Fleming JB, Lee JE, Varadhachary GR, Sahai SK, Katz MHG. Physical activity and exercise during preoperative pancreatic cancer treatment. Support Care Cancer 2019;27:2275-84. [PMID: 30334105 DOI: 10.1007/s00520-018-4493-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
251 D'amico AV, Chen M, Renshaw AA, Loffredo M, Kantoff PW. Interval to Testosterone Recovery After Hormonal Therapy for Prostate Cancer and Risk of Death. International Journal of Radiation Oncology*Biology*Physics 2009;75:10-5. [DOI: 10.1016/j.ijrobp.2008.10.082] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
252 Lee YK, Hong N, Park SH, Shin DY, Lee CR, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY, Lee EJ. The relationship of comorbidities to mortality and cause of death in patients with differentiated thyroid carcinoma. Sci Rep 2019;9:11435. [PMID: 31391492 DOI: 10.1038/s41598-019-47898-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
253 Fiorica F, Cartei F, Ursino S, Stefanelli A, Zagatti Y, Berretta S, Figura S, Maugeri D, Zanet E, Spartà D, La Morella C, Tirelli U, Berretta M. Safety and feasibility of radiotherapy treatment in elderly non-small-cell lung cancer (NSCLC) patients. Archives of Gerontology and Geriatrics 2010;50:185-91. [DOI: 10.1016/j.archger.2009.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
254 Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR. Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precis Oncol 2019;3:PO. [PMID: 32914036 DOI: 10.1200/PO.19.00001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck 2017;39:2512-8. [PMID: 28963806 DOI: 10.1002/hed.24918] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
256 Luque-Fernandez MA, Gonçalves K, Salamanca-Fernández E, Redondo-Sanchez D, Lee SF, Rodríguez-Barranco M, Carmona-García MC, Marcos-Gragera R, Sánchez MJ. Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study. Eur J Cancer 2020;129:4-14. [PMID: 32114366 DOI: 10.1016/j.ejca.2020.01.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
257 To T, Okera M, Prouse J, Prowse R, Singhal N. Infancy of an Australian geriatric oncology program—characteristics of the first 200 patients. Journal of Geriatric Oncology 2010;1:81-6. [DOI: 10.1016/j.jgo.2010.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
258 Szturz P, Vermorken JB. Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. Front Oncol 2016;6:199. [PMID: 27630826 DOI: 10.3389/fonc.2016.00199] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
259 Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol. 2010;28:4086-4093. [PMID: 20644100 DOI: 10.1200/jco.2009.27.0579] [Cited by in Crossref: 141] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
260 Pilleron S, Sarfati D, Janssen-heijnen M, Vignat J, Ferlay J, Bray F, Soerjomataram I. Global cancer incidence in older adults, 2012 and 2035: A population-based study: Global cancer incidence in older adults. Int J Cancer 2019;144:49-58. [DOI: 10.1002/ijc.31664] [Cited by in Crossref: 124] [Cited by in F6Publishing: 88] [Article Influence: 41.3] [Reference Citation Analysis]
261 Keil F, Hartl M, Altorjai G, Berghold A, Riedl R, Pecherstorfer M, Mayrbäurl B, De Vries A, Schuster J, Hackl J, Füreder T, Melchardt T, Burian M, Greil R. Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial. Eur J Cancer 2021;151:201-10. [PMID: 34022697 DOI: 10.1016/j.ejca.2021.03.051] [Reference Citation Analysis]
262 Okuyemi OT, Piccirillo JF, Spitznagel E. TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival. Head Neck 2014;36:1481-9. [PMID: 23996811 DOI: 10.1002/hed.23486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
263 Wu Y, Zhang B, Huang Z, Ruan Y, Huang Z. Study of surgical treatment for elderly patients with head and neck cancer. Int J Oral Maxillofac Surg 2018;47:824-9. [PMID: 29429844 DOI: 10.1016/j.ijom.2018.01.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
264 Lin AJ, Gang M, Rao YJ, Campian J, Daly M, Gay H, Oppelt P, Jackson RS, Rich J, Paniello R, Zevallos J, Hallahan D, Adkins D, Thorstad W. Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers. JAMA Otolaryngol Head Neck Surg 2019;145:413-21. [PMID: 30920592 DOI: 10.1001/jamaoto.2019.0034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
265 Tetsche MS, Nørgaard M, Jacobsen J, Wogelius P, Sørensen HT. Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study. Int J Gynecol Cancer 2008;18:421-7. [PMID: 17692093 DOI: 10.1111/j.1525-1438.2007.01036.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
266 Do W, Elzerman T, de Bree R, Rosenberg A, Forouzanfar T, Van Cann EM. Is low or high body mass index in patients operated for oral squamous cell carcinoma associated with the perioperative complication rate? Int J Oral Maxillofac Surg 2021;50:591-7. [PMID: 32861557 DOI: 10.1016/j.ijom.2020.07.023] [Reference Citation Analysis]
267 Bagni K, Chen IM, Johansen AZ, Dehlendorff C, Jensen BV, Hansen CP, Preus Hasselby J, Holländer NH, Nissen M, Bjerregaard JK, Pfeiffer P, Yilmaz MK, Rasmussen LS, Nielsen SE, Johansen JS. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer. Eur J Cancer Care (Engl) 2020;29:e13219. [PMID: 31908093 DOI: 10.1111/ecc.13219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
268 Billmeier SE, Ayanian JZ, He Y, Jaklitsch MT, Rogers SO. Predictors of Nursing Home Admission, Severe Functional Impairment, or Death One Year After Surgery for Non-Small Cell Lung Cancer. Annals of Surgery 2013;257:555-63. [DOI: 10.1097/sla.0b013e31828353af] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
269 Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer. 2006;42:3015-3021. [PMID: 16797967 DOI: 10.1016/j.ejca.2005.10.032] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
270 Agarwal M, Thareja N, Benjamin M, Akhondi A, Mitchell GD. Tyrosine Kinase Inhibitor-Induced Hypertension. Curr Oncol Rep 2018;20. [DOI: 10.1007/s11912-018-0708-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 8.7] [Reference Citation Analysis]
271 Arthur AE, Goss AM, Demark-Wahnefried W, Mondul AM, Fontaine KR, Chen YT, Carroll WR, Spencer SA, Rogers LQ, Rozek LS, Wolf GT, Gower BA; University of Michigan Head and Neck SPORE Program. Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study. Int J Cancer 2018;143:1105-13. [PMID: 29604042 DOI: 10.1002/ijc.31413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
272 Rodrigues G, Sanatani M. Age and comorbidity considerations related to radiotherapy and chemotherapy administration. Semin Radiat Oncol 2012;22:277-83. [PMID: 22985810 DOI: 10.1016/j.semradonc.2012.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
273 Hall SF, Liu FF, O'Sullivan B, Shi W, Rohland S, Griffiths R, Groome P. Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study. Br J Cancer 2017;117:1105-12. [PMID: 28829763 DOI: 10.1038/bjc.2017.275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
274 Singh LK, Arora RD, Tikka SK, Shukla A, Singh S, Mahant S, Verma S. Brief Intervention for Tobacco when Diagnosed with Oral Cancer (BITDOC): Study protocol of a randomized clinical trial studying efficacy of brief tobacco cessation intervention, Chhattisgarh, India. Tob Prev Cessat 2020;6:4. [PMID: 32548341 DOI: 10.18332/tpc/115028] [Reference Citation Analysis]
275 Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans T, Langer C. Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapies. Clin Lung Cancer 2013;14:581-91. [PMID: 23827517 DOI: 10.1016/j.cllc.2013.05.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
276 Peters TT, van Dijk BA, Roodenburg JL, van der Laan BF, Halmos GB. Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer. Ann Surg Oncol 2014;21:963-70. [PMID: 24248531 DOI: 10.1245/s10434-013-3375-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
277 Ali A, Song YP, Mehta S, Mistry H, Conroy R, Coyle C, Logue J, Tran A, Wylie J, Janjua T, Joseph L, Joseph J, Choudhury A. Palliative Radiation Therapy in Bladder Cancer—Importance of Patient Selection: A Retrospective Multicenter Study. International Journal of Radiation Oncology*Biology*Physics 2019;105:389-93. [DOI: 10.1016/j.ijrobp.2019.06.2541] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
278 Olivieri A, Gini G, Bocci C, Montanari M, Trappolini S, Olivieri J, Brunori M, Catarini M, Guiducci B, Isidori A, Alesiani F, Giuliodori L, Marcellini M, Visani G, Poloni A, Leoni P. Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. Oncologist 2012;17:663-72. [PMID: 22531362 DOI: 10.1634/theoncologist.2011-0355] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
279 Reitzel LR, Nguyen N, Zafereo ME, Li G, Wei Q, Sturgis EM. Neighborhood deprivation and clinical outcomes among head and neck cancer patients. Health Place 2012;18:861-8. [PMID: 22445028 DOI: 10.1016/j.healthplace.2012.03.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
280 Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer. J Clin Oncol 2013;31:475-81. [PMID: 23269988 DOI: 10.1200/JCO.2012.44.1170] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
281 Becker H, Rechis R, Kang SJ, Brown A. The post-treatment experience of cancer survivors with pre-existing cardiopulmonary disease. Support Care Cancer 2011;19:1351-5. [PMID: 20658347 DOI: 10.1007/s00520-010-0957-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
282 Kang S, Kim HS, Kim W, Kim JH, Kang SH, Han I. Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma. Clin Orthop Surg 2015;7:120-30. [PMID: 25729528 DOI: 10.4055/cios.2015.7.1.120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
283 Østhus AA, Aarstad AKH, Olofsson J, Aarstad HJ. Prediction of 5 year survival from level of perceived distress in newly diagnosed head and neck squamous cell carcinoma patients. Oral Oncology 2013;49:964-9. [DOI: 10.1016/j.oraloncology.2013.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
284 Proctor SJ, Wilkinson J, Jones G, Watson GC, Lucraft HH, Mainou-fowler T, Culligan D, Galloway MJ, Wood KM, Mcnally RJQ, James PW, Goodlad JR. Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study. Blood 2012;119:6005-15. [DOI: 10.1182/blood-2011-12-396556] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
285 Wass M, Hitz F, Schaffrath J, Müller-Tidow C, Müller LP. Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia. PLoS One 2016;11:e0164587. [PMID: 27732646 DOI: 10.1371/journal.pone.0164587] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
286 Kimmick G, Edmond SN, Bosworth HB, Peppercorn J, Marcom PK, Blackwell K, Keefe FJ, Shelby RA. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy. Breast 2015;24:630-6. [PMID: 26189978 DOI: 10.1016/j.breast.2015.06.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
287 Chandra RA, Chen M, Zhang D, Loffredo M, D'amico AV. Age, Comorbidity, and the Risk of Prostate Cancer-Specific Mortality in Men With Biopsy Gleason Score 4+3: Implications on Patient Selection for Multiparametric MRI. Clinical Genitourinary Cancer 2015;13:400-5. [DOI: 10.1016/j.clgc.2015.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
288 Kumar P, Casarett D, Corcoran A, Desai K, Li Q, Chen J, Langer C, Mao JJ. Utilization of supportive and palliative care services among oncology outpatients at one academic cancer center: determinants of use and barriers to access. J Palliat Med 2012;15:923-30. [PMID: 22731514 DOI: 10.1089/jpm.2011.0217] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.8] [Reference Citation Analysis]
289 Mann CD, Palser T, Briggs CD, Cameron I, Rees M, Buckles J, Berry DP. A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery. HPB (Oxford) 2010;12:380-8. [PMID: 20662788 DOI: 10.1111/j.1477-2574.2010.00179.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
290 Sandfeld-paulsen B, Meldgaard P, Aggerholm-pedersen N. Comorbidity in Lung Cancer: A Prospective Cohort Study of Self-Reported versus Register-Based Comorbidity. Journal of Thoracic Oncology 2018;13:54-62. [DOI: 10.1016/j.jtho.2017.10.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
291 White RH, Chew H, Wun T. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk? Thromb Res 2007;120 Suppl 2:S29-40. [PMID: 18023711 DOI: 10.1016/S0049-3848(07)70128-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
292 Palumbo A, Bringhen S, Ludwig H, Dimopoulos MA, Bladé J, Mateos MV, Rosiñol L, Boccadoro M, Cavo M, Lokhorst H, Zweegman S, Terpos E, Davies F, Driessen C, Gimsing P, Gramatzki M, Hàjek R, Johnsen HE, Leal Da Costa F, Sezer O, Spencer A, Beksac M, Morgan G, Einsele H, San Miguel JF, Sonneveld P. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood 2011;118:4519-29. [PMID: 21841166 DOI: 10.1182/blood-2011-06-358812] [Cited by in Crossref: 225] [Cited by in F6Publishing: 179] [Article Influence: 22.5] [Reference Citation Analysis]
293 Rim CH, Yoon WS, Lee JA, Yang DS, Lee NK, Park YJ, Kim CY. Factors predicting intolerance to definitive conventional radiotherapy in geriatric patients. Strahlenther Onkol 2018;194:894-903. [DOI: 10.1007/s00066-018-1318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
294 Sforza N, Rosenfarb J, Rujelman R, Rosmarin M, Blanc E, Frigerio C, Fossati P, Caruso D, Faingold C, Meroño T, Brenta G. Hypothyroidism in hospitalized elderly patients: a sign of worse prognosis. J Endocrinol Invest 2017;40:1303-10. [DOI: 10.1007/s40618-017-0690-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
295 Fanucchi O, Ambrogi MC, Aprile V, Cioni R, Cappelli C, Melfi F, Massimetti G, Mussi A. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience. Interact Cardiovasc Thorac Surg 2016;23:57-64. [PMID: 27059068 DOI: 10.1093/icvts/ivw089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
296 Kim DW, Chen MH, Huland H, Graefen M, Tilki D, D'Amico AV. Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer. JAMA Netw Open 2020;3:e202041. [PMID: 32239219 DOI: 10.1001/jamanetworkopen.2020.2041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Hashim D, Carioli G, Malvezzi M, Bertuccio P, Waxman S, Negri E, La Vecchia C, Boffetta P. Cancer mortality in the oldest old: a global overview. Aging (Albany NY) 2020;12:16744-58. [PMID: 32882684 DOI: 10.18632/aging.103503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
298 Deutsch BC, Collopy C, Kallogjeri D, Piccirillo JF. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment. JAMA Otolaryngol Head Neck Surg 2021;147:182-9. [PMID: 33300954 DOI: 10.1001/jamaoto.2020.4620] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Halmos GB, Peters TT, Roodenburg JL, van Dijk BA, van der Laan BF. Comorbidity, complications, and survival of sinonasal malignancies in young and elderly treated by surgery. Otolaryngol Head Neck Surg 2013;148:860-6. [PMID: 23389240 DOI: 10.1177/0194599813477354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
300 Legler A, Bradley EH, Carlson MD. The effect of comorbidity burden on health care utilization for patients with cancer using hospice. J Palliat Med 2011;14:751-6. [PMID: 21548813 DOI: 10.1089/jpm.2010.0504] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
301 Pallis A, Gridelli C. Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer? Cancer Treatment Reviews 2010;36:436-41. [DOI: 10.1016/j.ctrv.2009.12.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
302 Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, Slatore CG. Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment. J Clin Oncol 2016;34:3984-91. [PMID: 27996350 DOI: 10.1200/JCO.2016.66.8459] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 10.4] [Reference Citation Analysis]
303 Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. J Am Coll Surg 2014;219:111-20. [PMID: 24856952 DOI: 10.1016/j.jamcollsurg.2014.02.023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
304 Chrischilles EA, McDowell BD, Rubenstein L, Charlton M, Pendergast J, Juarez GY, Arora NK. Survivorship care planning and its influence on long-term patient-reported outcomes among colorectal and lung cancer survivors: the CanCORS disease-free survivor follow-up study. J Cancer Surviv 2015;9:269-78. [PMID: 25354481 DOI: 10.1007/s11764-014-0406-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
305 Muffly LS, Boulukos M, Swanson K, Kocherginsky M, Cerro PD, Schroeder L, Pape L, Extermann M, Van Besien K, Artz AS. Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients. Biology of Blood and Marrow Transplantation 2013;19:429-34. [DOI: 10.1016/j.bbmt.2012.11.006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 9.4] [Reference Citation Analysis]
306 Lee MK, Nalliah RP, Kim MK, Elangovan S, Allareddy V, Kumar-gajendrareddy P, Allareddy V. Prevalence and impact of complications on outcomes in patients hospitalized for oral and oropharyngeal cancer treatment. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2011;112:581-91. [DOI: 10.1016/j.tripleo.2011.06.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
307 Urvay SE, Yucel B, Erdis E, Turan N. Prognostic Factors in Stage III Non-Small-Cell Lung Cancer Patients. Asian Pac J Cancer Prev 2016;17:4693-7. [PMID: 27893199 DOI: 10.22034/apjcp.2016.17.10.4693] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
308 Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MHG. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol. 2017;24:2031-2039. [PMID: 28124275 DOI: 10.1245/s10434-017-5777-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
309 Wu YH, Jhan JH, Ke HL, Tseng SI, Chang YH, Yeh HC, Li CC, Lee YC. Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study. Int J Clin Pharm 2020;42:1433-9. [PMID: 32951178 DOI: 10.1007/s11096-020-01143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
310 Kim Y, van Ryn M, Jensen RE, Griffin JM, Potosky A, Rowland J. Effects of gender and depressive symptoms on quality of life among colorectal and lung cancer patients and their family caregivers. Psychooncology 2015;24:95-105. [PMID: 24831223 DOI: 10.1002/pon.3580] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
311 Amini A, Jones BL, McDermott JD, Serracino HS, Jimeno A, Raben D, Ghosh D, Bowles DW, Karam SD. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base. Cancer 2016;122:1533-43. [PMID: 26969811 DOI: 10.1002/cncr.29956] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
312 Fairey AS, Jacobsen NB, Chetner MP, Mador DR, Metcalfe JB, Moore RB, Rourke KF, Todd GT, Venner PM, Voaklander DC, Estey EP. Associations Between Comorbidity, and Overall Survival and Bladder Cancer Specific Survival After Radical Cystectomy: Results From the Alberta Urology Institute Radical Cystectomy Database. Journal of Urology 2009;182:85-93. [DOI: 10.1016/j.juro.2008.11.111] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
313 He X, Clarke SJ, McLachlan AJ. Clinical pharmacology of chemotherapy agents in older people with cancer. Curr Gerontol Geriatr Res 2011;2011:628670. [PMID: 21845189 DOI: 10.1155/2011/628670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
314 Fancy T, Huang AT, Kass JI, Lamarre ED, Tassone P, Mantravadi AV, Alwani MM, Subbarayan RS, Bur AM, Worley ML, Graboyes EM, McMullen CP, Azoulay O, Wax MK, Cave TB, Al-Khudari S, Abello EH, Higgins KM, Ryan JT, Orzell SC, Goldman RA, Vimawala S, Fernandes RP, Abdelmalik M, Rajasekaran K, L'Esperance HE, Kallogjeri D, Rich JT. Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction. JAMA Otolaryngol Head Neck Surg 2019;145:1150-7. [PMID: 31600390 DOI: 10.1001/jamaoto.2019.2768] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
315 Polednak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 2006;30:466-72. [PMID: 17069990 DOI: 10.1016/j.cdp.2006.07.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
316 Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract 2015;11:145-50. [PMID: 25515717 DOI: 10.1200/JOP.2014.001542] [Cited by in Crossref: 157] [Cited by in F6Publishing: 70] [Article Influence: 22.4] [Reference Citation Analysis]
317 Roxburgh C, Mcdonald A, Salmond J, Oien K, Anderson J, Mckee R, Horgan P, Mcmillan D. Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors. Int J Colorectal Dis 2011;26:483-92. [DOI: 10.1007/s00384-010-1120-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
318 Geraci JM, Escalante CP, Freeman JL, Goodwin JS. Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J Clin Oncol 2005;23:7399-404. [PMID: 16234509 DOI: 10.1200/JCO.2004.00.9753] [Cited by in Crossref: 58] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
319 Milan A, Puglisi E, Ferrari L, Bruno G, Losano I, Veglio F. Arterial hypertension and cancer: Arterial hypertension and cancer. Int J Cancer 2014;134:2269-77. [DOI: 10.1002/ijc.28334] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
320 Alexander M, Evans SM, Stirling RG, Wolfe R, Officer A, MacManus M, Solomon B, Burbury K, Ball D. The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study. J Thorac Oncol 2016;11:748-57. [PMID: 26851495 DOI: 10.1016/j.jtho.2016.01.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
321 Derks W, de Leeuw RJ, Hordijk GJ. Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival: . Current Opinion in Otolaryngology & Head and Neck Surgery 2005;13:92-6. [DOI: 10.1097/01.moo.0000156169.63204.39] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
322 Corkum M, Urquhart R, Kendell C, Burge F, Porter G, Johnston G. Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review. Cancer Causes Control 2012;23:213-20. [PMID: 22101505 DOI: 10.1007/s10552-011-9875-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
323 D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer. Cancer 2008;113:3290-7. [PMID: 18980297 DOI: 10.1002/cncr.23970] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
324 Terret C, Albrand G, Rainfray M, Soubeyran P. Impact of comorbidities on the treatment of non-Hodgkin’s lymphoma: a systematic review. Expert Review of Hematology 2015;8:329-41. [DOI: 10.1586/17474086.2015.1024650] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
325 Melfi FM, Fanucchi O, Davini F, Romano G, Lucchi M, Dini P, Ambrogi MC, Mussi A. Robotic lobectomy for lung cancer: evolution in technique and technology. Eur J Cardiothorac Surg 2014;46:626-30; discussion 630-1. [PMID: 24616391 DOI: 10.1093/ejcts/ezu079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
326 Butts CA, Ding K, Seymour L, Twumasi-Ankrah P, Graham B, Gandara D, Johnson DH, Kesler KA, Green M, Vincent M, Cormier Y, Goss G, Findlay B, Johnston M, Tsao MS, Shepherd FA. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol. 2010;28:29-34. [PMID: 19933915 DOI: 10.1200/jco.2009.24.0333] [Cited by in Crossref: 231] [Cited by in F6Publishing: 84] [Article Influence: 19.3] [Reference Citation Analysis]
327 Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Queneherve L. Prognostic factors for stage III colon cancer in patients 80 years of age and older. Int J Colorectal Dis 2021;36:811-9. [PMID: 33528749 DOI: 10.1007/s00384-021-03861-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
328 Karimi M, Cohan N. Cancer-associated thrombosis. Open Cardiovasc Med J 2010;4:78-82. [PMID: 20360976 DOI: 10.2174/1874192401004020078] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
329 Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol 2009;3:186-94. [PMID: 20596971 DOI: 10.1007/s12105-009-0126-1] [Cited by in Crossref: 137] [Cited by in F6Publishing: 117] [Article Influence: 11.4] [Reference Citation Analysis]
330 Shuman AG, Terrell JE, Light E, Wolf GT, Bradford CR, Chepeha D, Jiang Y, McLean S, Ghanem TA, Duffy SA. Predictors of pain among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2012;138:1147-54. [PMID: 23165353 DOI: 10.1001/jamaoto.2013.853] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
331 Lango MN, Galloway TJ, Mehra R, Ebersole B, Liu JC, Moran K, Ridge JA. Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation: Baseline Patient-Reported Dysphagia and Gastrostomy in HNSCC. Head Neck 2016;38:E1318-24. [DOI: 10.1002/hed.24220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
332 Matsumoto T, Hasegawa S, Matsumoto S, Horimatsu T, Okoshi K, Yamada M, Kawada K, Sakai Y. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Dis Colon Rectum 2014;57:679-86. [PMID: 24807591 DOI: 10.1097/DCR.0000000000000025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
333 Martin MY, Fouad MN, Oster RA, Schrag D, Urmie J, Sanders S, Pisu M. What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups. Support Care Cancer 2014;22:233-44. [PMID: 24037412 DOI: 10.1007/s00520-013-1958-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
334 Janssen-Heijnen ML, Maas HA, Siesling S, Koning CC, Coebergh JW, Groen HJ. Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80. Ann Oncol 2012;23:954-60. [PMID: 21690233 DOI: 10.1093/annonc/mdr303] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
335 D'Amico AV, Xie W, McMahon E, Loffredo M, Medeiros S, Joseph D, Denham J, Kumar P, Bubley G, Sullivan M, Hellwig R, Carlos Vera J, Freter R, Jeffrey Baker W, Wong JY, Renshaw AA, Kantoff PW. Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial. J Clin Oncol 2021;39:2938-47. [PMID: 34197181 DOI: 10.1200/JCO.21.00596] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Munro A, Brown M, Niblock P, Steele R, Carey F. Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer 2015;15:686. [PMID: 26463599 DOI: 10.1186/s12885-015-1683-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
337 Chen LM, Li G, Reitzel LR, Pytynia KB, Zafereo ME, Wei Q, Sturgis EM. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila) 2009;2:782-91. [PMID: 19737985 DOI: 10.1158/1940-6207.CAPR-09-0154] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
338 Graboyes EM, Townsend ME, Kallogjeri D, Piccirillo JF, Nussenbaum B. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 2016;142:1154-63. [PMID: 27435696 DOI: 10.1001/jamaoto.2016.0657] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
339 Hornbrook MC, Malin J, Weeks JC, Makgoeng SB, Keating NL, Potosky AL. Did changes in drug reimbursement after the medicare modernization act affect chemotherapy prescribing? J Clin Oncol 2014;32:4042-9. [PMID: 25267762 DOI: 10.1200/JCO.2013.52.6780] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
340 Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Morrow M, Gemignani ML. Determinants of outcome in elderly patients with positive sentinel lymph nodes. Am J Surg 2011;201:734-40. [PMID: 20619395 DOI: 10.1016/j.amjsurg.2010.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
341 Nguyen PL, Chen M, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'amico AV. Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence. Cancer 2010;116:610-5. [DOI: 10.1002/cncr.24818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
342 Koppert LB, Lemmens VE, Coebergh JW, Steyerberg EW, Wijnhoven BP, Tilanus HW, Janssen-Heijnen ML. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg. 2012;99:1693-1700. [PMID: 23132417 DOI: 10.1002/bjs.8952] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
343 Farrell JJ. Editorial: Stopping Pancreatic Cyst Surveillance? Am J Gastroenterol 2017;112:1162-4. [PMID: 28725064 DOI: 10.1038/ajg.2017.163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
344 Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113:750-757. [PMID: 18536030 DOI: 10.1002/cncr.23615] [Cited by in Crossref: 205] [Cited by in F6Publishing: 186] [Article Influence: 15.8] [Reference Citation Analysis]
345 Kim JW, Kim YJ, Lee KW, Chang H, Lee JO, Kim KI, Bang SM, Lee JS, Kim CH, Kim JH. The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer 2014;22:773-81. [PMID: 24287502 DOI: 10.1007/s00520-013-2033-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
346 Nguyen PL, Alibhai SM, Basaria S, D'Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B, Smith MR. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 2015;67:825-36. [PMID: 25097095 DOI: 10.1016/j.eururo.2014.07.010] [Cited by in Crossref: 332] [Cited by in F6Publishing: 239] [Article Influence: 47.4] [Reference Citation Analysis]
347 Bornbaum CC, Doyle PC, Skarakis-Doyle E, Theurer JA. A critical exploration of the International Classification of Functioning, Disability, and Health (ICF) framework from the perspective of oncology: recommendations for revision. J Multidiscip Healthc 2013;6:75-86. [PMID: 23526147 DOI: 10.2147/JMDH.S40020] [Cited by in Crossref: 19] [Article Influence: 2.4] [Reference Citation Analysis]
348 Stairmand J, Signal L, Sarfati D, Jackson C, Batten L, Holdaway M, Cunningham C. Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review. Ann Oncol. 2015;26:1325-1332. [PMID: 25605751 DOI: 10.1093/annonc/mdv025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
349 Wieringa A, Boslooper K, Hoogendoorn M, Joosten P, Beerden T, Storm H, Kibbelaar RE, Veldhuis GJ, van Kamp H, van Rees B, Kluin-Nelemans HC, Veeger NJ, van Roon EN. Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study. Br J Haematol 2014;165:489-96. [PMID: 24754632 DOI: 10.1111/bjh.12765] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
350 Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment: Cancer and Comorbidity. CA: A Cancer Journal for Clinicians 2016;66:337-50. [DOI: 10.3322/caac.21342] [Cited by in Crossref: 223] [Cited by in F6Publishing: 172] [Article Influence: 44.6] [Reference Citation Analysis]
351 Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 2010;32:728-36. [PMID: 19827120 DOI: 10.1002/hed.21245] [Cited by in Crossref: 19] [Cited by in F6Publishing: 46] [Article Influence: 1.7] [Reference Citation Analysis]
352 Hines RB, Chatla C, Bumpers HL, Waterbor JW, McGwin G Jr, Funkhouser E, Coffey CS, Posey J, Manne U. Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol. 2009;27:4339-4345. [PMID: 19652054 DOI: 10.1200/jco.2009.22.4758] [Cited by in Crossref: 68] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
353 Duffy SA, Teknos T, Taylor JM, Fowler KE, Islam M, Wolf GT, McLean S, Ghanem TA, Terrell JE. Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:374-81. [PMID: 23300019 DOI: 10.1158/1055-9965.EPI-12-0987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
354 Arthur AE, Bellile EL, Rozek LS, Peterson KE, Ren J, Harris E, Mueller C, Jolly S, Peterson LA, Wolf GT, Djuric Z. Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival. Head Neck 2016;38 Suppl 1:E1591-7. [PMID: 26614223 DOI: 10.1002/hed.24283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
355 Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013;31:558-564. [PMID: 23295799 DOI: 10.1200/jco.2012.43.7954] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 5.9] [Reference Citation Analysis]
356 Schwarz L, Bruno M, Parker NH, Prakash L, Mise Y, Lee JE, Vauthey J, Aloia TA, Conrad C, Fleming JB, Katz MHG. Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Ann Surg Oncol 2015;22:3522-9. [DOI: 10.1245/s10434-015-4437-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
357 Kallogjeri D, Piccirillo JF, Spitznagel EL, Steyerberg EW. Comparison of Scoring Methods for ACE-27: Simpler Is Better. J Geriatr Oncol. 2012;3:238-245. [PMID: 22712031 DOI: 10.1016/j.jgo.2012.01.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
358 Bérubé S, Provencher L, Robert J, Jacob S, Hébert-Croteau N, Lemieux J, Duchesne T, Brisson J. Quantitative exploration of possible reasons for the recent improvement in breast cancer survival. Breast Cancer Res Treat 2007;106:419-31. [PMID: 17268811 DOI: 10.1007/s10549-007-9503-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
359 Peters TT, Langendijk JA, Plaat BE, Wedman J, Roodenburg JL, van Dijk BA, Sluiter WJ, van der Laan BF, Halmos GB. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: A matched control study. Oral Oncology 2011;47:1159-64. [DOI: 10.1016/j.oraloncology.2011.08.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
360 Giacalone NJ, Wu J, Chen MH, Renshaw A, Loffredo M, Kantoff PW, D'Amico AV. Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial. J Clin Oncol 2016;34:3781-6. [PMID: 27601545 DOI: 10.1200/JCO.2016.68.4530] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
361 van Osch FHM, Jochems SHJ, Reulen RC, Pirrie SJ, Nekeman D, Wesselius A, James ND, Wallace DMA, Cheng KK, van Schooten FJ, Bryan RT, Zeegers MP. The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study. Cancer Causes Control 2018;29:675-83. [PMID: 29846846 DOI: 10.1007/s10552-018-1046-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
362 Jani BD, Hanlon P, Nicholl BI, McQueenie R, Gallacher KI, Lee D, Mair FS. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort. BMC Med 2019;17:74. [PMID: 30967141 DOI: 10.1186/s12916-019-1305-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 27.0] [Reference Citation Analysis]
363 Ta AD, Bolton DM, Dimech MK, White V, Davis ID, Coory M, Millar J, Giles G. Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs. BJU Int 2013;112 Suppl 2:36-43. [PMID: 24127675 DOI: 10.1111/bju.12204] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
364 De Felice F, Vetrone L, Bulzonetti N, Caiazzo R, Marampon F, Musio D, Tombolini V. Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma. Med Oncol 2019;36:68. [PMID: 31190132 DOI: 10.1007/s12032-019-1292-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
365 De Felice F, Crocetti D, Maiuri V, Parisi M, Marampon F, Izzo L, De Toma G, Musio D, Tombolini V. Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients. Curr Treat Options Oncol 2020;21:1. [PMID: 31927649 DOI: 10.1007/s11864-019-0692-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
366 Sharma A, Schwartz SM, Méndez E. Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer. Cancer 2013;119:1845-52. [PMID: 23456789 DOI: 10.1002/cncr.27976] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
367 Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol 2011;29:3503-9. [PMID: 21844503 DOI: 10.1200/JCO.2011.35.7301] [Cited by in Crossref: 130] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
368 Khan S, Nepple KG, Kibel AS, Sandhu G, Kallogjeri D, Strope S, Grubb R 3rd, Wolin KY, Sutcliffe S. The association of marital status and mortality among men with early-stage prostate cancer treated with radical prostatectomy: insight into post-prostatectomy survival strategies. Cancer Causes Control 2019;30:871-6. [PMID: 31214808 DOI: 10.1007/s10552-019-01194-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
369 Sanoff HK, Carpenter WR, Martin CF, Sargent DJ, Meyerhardt JA, Stürmer T, Fine JP, Weeks J, Niland J, Kahn KL, Schymura MJ, Schrag D. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst 2012;104:211-27. [PMID: 22266473 DOI: 10.1093/jnci/djr524] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
370 Lee GH, Lee IR, Park SJ, Kim JH, Oh JY, Shin JI. Hypertensive crisis in children: an experience in a single tertiary care center in Korea. Clin Hypertens 2015;22:10. [PMID: 27092268 DOI: 10.1186/s40885-016-0040-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
371 Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev 2011;20:1996-2005. [PMID: 21980007 DOI: 10.1158/1055-9965.EPI-11-0729] [Cited by in Crossref: 292] [Cited by in F6Publishing: 132] [Article Influence: 32.4] [Reference Citation Analysis]
372 Nagele P, Rao LK, Penta M, Kallogjeri D, Spitznagel EL, Cavallone LF, Nussenbaum B, Piccirillo JF. Postoperative myocardial injury after major head and neck cancer surgery. Head Neck 2011;33:1085-91. [PMID: 20886662 DOI: 10.1002/hed.21577] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
373 Griffiths EA, Carraway HE, Chandhok NS, Prebet T. Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia. Leuk Res 2020;91:106339. [PMID: 32146154 DOI: 10.1016/j.leukres.2020.106339] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
374 Deshpande AD, Sefko JA, Jeffe DB, Schootman M. The association between chronic disease burden and quality of life among breast cancer survivors in Missouri. Breast Cancer Res Treat 2011;129:877-86. [PMID: 21519836 DOI: 10.1007/s10549-011-1525-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
375 Chen SY, Sinha P, Last A, Ettyreddy A, Kallogjeri D, Pipkorn P, Rich JT, Zevallos JP, Paniello R, Puram SV, Van Abel K, Moore EJ, Oppelt P, Palka K, Adkins D, Daly M, Gay H, Thorstad WL, Jackson RS. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery. JAMA Otolaryngol Head Neck Surg 2021;147:16-22. [PMID: 33151273 DOI: 10.1001/jamaoto.2020.3870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
376 Bernad IP, Trufero JM, Urquizu LC, Pazo Cid RA, de Miguel AC, Agustin MJ, Lanzuela M, Antón A. Activity of weekly paclitaxel-cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors. Clin Transl Oncol 2017;19:769-76. [PMID: 28120324 DOI: 10.1007/s12094-016-1604-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
377 Manchikanti L, Manchikanti KN, Kaye AD, Kaye AM, Hirsch JA. Challenges and concerns of persistent opioid use in cancer patients. Expert Rev Anticancer Ther 2018;18:705-18. [PMID: 29739242 DOI: 10.1080/14737140.2018.1474103] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
378 Noer MC, Sperling CD, Antonsen SL, Ottesen B, Christensen IJ, Høgdall C. A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients. Gynecol Oncol 2016;141:471-8. [PMID: 27056103 DOI: 10.1016/j.ygyno.2016.03.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
379 Schootman M, Deshpande AD, Pruitt S, Aft R, Jeffe DB. Estimated effects of potential interventions to prevent decreases in self-rated health among breast cancer survivors. Ann Epidemiol 2012;22:79-86. [PMID: 22226030 DOI: 10.1016/j.annepidem.2011.10.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
380 Kehl KL, Lamont EB, Mcneil BJ, Bozeman SR, Kelley MJ, Keating NL. Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer. Journal of Geriatric Oncology 2015;6:202-10. [DOI: 10.1016/j.jgo.2015.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
381 Kidoguchi S, Sugano N, Tokudome G, Yokoo T, Yano Y, Hatake K, Nishiyama A. New Concept of Onco-Hypertension and Future Perspectives. Hypertension 2021;77:16-27. [PMID: 33222548 DOI: 10.1161/HYPERTENSIONAHA.120.16044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
382 Yutaka Y, Sonobe M, Kawaguchi A, Hamaji M, Nakajima D, Ohsumi A, Menju T, Chen-Yoshikawa TF, Sato T, Date H. Prognostic impact of preoperative comorbidities in geriatric patients with early-stage lung cancer: Significance of sublobar resection as a compromise procedure. Lung Cancer 2018;125:192-7. [PMID: 30429019 DOI: 10.1016/j.lungcan.2018.09.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
383 Izzedine H, Ederhy S, Goldwasser F, Soria JC, Milano G, Cohen A, Khayat D, Spano JP. Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol 2009;20:807-15. [PMID: 19150949 DOI: 10.1093/annonc/mdn713] [Cited by in Crossref: 227] [Cited by in F6Publishing: 166] [Article Influence: 18.9] [Reference Citation Analysis]
384 Kovtun KA, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV. Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer. Cancer 2016;122:3608-14. [PMID: 27490845 DOI: 10.1002/cncr.30224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
385 Zafar SY, Malin JL, Grambow SC, Abbott DH, Kolimaga JT, Zullig LL, Weeks JC, Ayanian JZ, Kahn KL, Ganz PA, Catalano PJ, West DW, Provenzale D; Cancer Care Outcomes Research & Surveillance CanCORS Consortium. Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study. Cancer 2013;119:854-62. [PMID: 22972673 DOI: 10.1002/cncr.27815] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
386 Essa H, Pettitt AR, Lip GYH. Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated. J Hum Hypertens 2021;35:301-3. [PMID: 32788664 DOI: 10.1038/s41371-020-00400-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Sperling C, Noer MC, Christensen IJ, Nielsen ML, Lidegaard Ø, Høgdall C. Comorbidity is an independent prognostic factor for the survival of ovarian cancer: a Danish register-based cohort study from a clinical database. Gynecol Oncol 2013;129:97-102. [PMID: 23290990 DOI: 10.1016/j.ygyno.2012.12.039] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
388 Gien LT, Sutradhar R, Thomas G, Covens A, Elit L, Rakovitch E, Fyles A, Khalifa MA, Liu Y, Barbera L. Does a groin node dissection in vulvar cancer affect groin recurrence and overall survival?: Results from a population-based cohort study. Gynecologic Oncology 2017;144:318-23. [DOI: 10.1016/j.ygyno.2016.11.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
389 Al Feghali KA, Robbins JR, Mahan M, Burmeister C, Khan NT, Rasool N, Munkarah A, Elshaikh MA. Predictive Capacity of 3 Comorbidity Indices in Estimating Survival Endpoints in Women With Early-Stage Endometrial Carcinoma. Int J Gynecol Cancer 2016;26:1455-60. [DOI: 10.1097/igc.0000000000000802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
390 Gould MK, Schultz EM, Wagner TH, Xu X, Ghaus SJ, Wallace RB, Provenzale D, Au DH. Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol 2011;6:875-83. [PMID: 21572580 DOI: 10.1097/JTO.0b013e31821671b6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
391 Miles RC, Narayan AK, Lopez DB, Lehman CD, Harvey HB, Mishra V, Glover M, Flores EJ. Chronic Medical Illness as a Risk Factor for Poor Mammography Screening Adherence. Journal of Women's Health 2019;28:1378-83. [DOI: 10.1089/jwh.2018.7315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
392 Ghebriou D, Avenin D, Caillet P, Mongiat-artus P, Durdux C, Massard C, Culine S. Mise au point du FRancilian Oncogeriatric Group (FROG) pour la prise en charge du cancer de vessie du sujet âgé. Bulletin du Cancer 2014;101:841-55. [DOI: 10.1684/bdc.2014.1939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Comorbidity Is a Prognostic Factor in Elderly Patients with Head and Neck Cancer. Ann Surg Oncol 2007;14:1449-57. [DOI: 10.1245/s10434-006-9296-1] [Cited by in Crossref: 111] [Cited by in F6Publishing: 84] [Article Influence: 7.9] [Reference Citation Analysis]
394 Seve P, Sawyer M, Hanson J, Broussolle C, Dumontet C, Mackey JR. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study. Cancer 2006;106:2058-66. [PMID: 16583433 DOI: 10.1002/cncr.21833] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
395 Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu X. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer. Journal of Geriatric Oncology 2018;9:214-20. [DOI: 10.1016/j.jgo.2017.11.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
396 Becker H, Kang SJ, Stuifbergen A. Predictors of quality of life for long-term cancer survivors with preexisting disabling conditions. Oncol Nurs Forum 2012;39:E122-31. [PMID: 22374500 DOI: 10.1188/12.ONF.E122-E131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
397 Twizeyimana L, Kim Y. Breast Cancer Screening Participation of Women with Chronic Diseases in Korea: Analysis of the 2012 Korean National Health and Nutrition Examination Survey. Asian Pac J Cancer Prev 2019;20:207-13. [PMID: 30678433 DOI: 10.31557/APJCP.2019.20.1.207] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
398 Gould MK, Wagner TH, Schultz EM, Xu X, Ghaus SJ, Provenzale D, Au DH. Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest 2014;145:839-47. [PMID: 24306819 DOI: 10.1378/chest.13-1073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
399 Tjostheim SS, Stepien RL, Markovic LE, Stein TJ. Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs. J Vet Intern Med 2016;30:951-7. [PMID: 27149912 DOI: 10.1111/jvim.13951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
400 Landrum MB, Keating NL, Lamont EB, Bozeman SR, Krasnow SH, Shulman L, Brown JR, Earle CC, Rabin M, McNeil BJ. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol 2012;30:1072-9. [PMID: 22393093 DOI: 10.1200/JCO.2011.35.6758] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
401 Hall SA, Kaufman JS. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer 2004;101:2899-2899. [DOI: 10.1002/cncr.20702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
402 Trautmann F, Singer S, Schmitt J. Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysis. Eur J Cancer Care (Engl) 2017;26. [PMID: 27957779 DOI: 10.1111/ecc.12605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
403 Palmer JL, Fisch MJ. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 2005;29:565-71. [PMID: 15963865 DOI: 10.1016/j.jpainsymman.2004.11.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
404 Lu Q, Lu JW, Wu Z, Liu XM, Li JH, Dong J, Yin GZ, Lv Y, Zhang XF. Perioperative outcome of elderly versus younger patients undergoing major hepatic or pancreatic surgery. Clin Interv Aging 2018;13:133-41. [PMID: 29416321 DOI: 10.2147/CIA.S153058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
405 Sheetz T, Lee CT. Frailty and geriatric assessment in urologic oncology. Current Opinion in Urology 2018;28:233-42. [DOI: 10.1097/mou.0000000000000501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
406 Bergström L, Ward EC, Finizia C. Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being. Support Care Cancer 2017;25:2683-90. [PMID: 28365896 DOI: 10.1007/s00520-017-3676-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
407 Zhang C, Sturgis EM, Zheng H, Song X, Wei P, Jin L, Chao L, Wei Q, Li G. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy. Int J Cancer 2014;134:1907-15. [PMID: 24122460 DOI: 10.1002/ijc.28512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
408 Patel RS, Mccluskey SA, Goldstein DP, Minkovich L, Irish JC, Brown DH, Gullane PJ, Lipa JE, Gilbert RW. Clinicopathologic and therapeutic risk factors for perioperative complications and prolonged hospital stay in free flap reconstruction of the head and neck. Head Neck 2010;32:1345-53. [DOI: 10.1002/hed.21331] [Cited by in Crossref: 108] [Cited by in F6Publishing: 85] [Article Influence: 9.8] [Reference Citation Analysis]
409 Shelby RA, Edmond SN, Wren AA, Keefe FJ, Peppercorn JM, Marcom PK, Blackwell KL, Kimmick GG. Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy. Support Care Cancer 2014;22:2851-9. [PMID: 24821365 DOI: 10.1007/s00520-014-2269-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
410 Østhus AA, Aarstad AKH, Olofsson J, Aarstad HJ. Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients. Eur Arch Otorhinolaryngol 2013;270:1721-8. [DOI: 10.1007/s00405-012-2207-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
411 Nguyen PL, Chen MH, Goldhaber SZ, Martin NE, Beard CJ, Dosoretz DE, Katin MJ, Ross R, Salenius SA, D’Amico AV. Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation. Cancer. 2011;117:406-413. [PMID: 21108457 DOI: 10.1002/cncr.25597] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
412 Roberts JC, Li G, Reitzel LR, Wei Q, Sturgis EM. No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis. Clin Cancer Res 2010;16:5019-27. [PMID: 20943762 DOI: 10.1158/1078-0432.CCR-10-0755] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
413 Vincent L, Leedy D, Masri SC, Cheng RK. Cardiovascular Disease and Cancer: Is There Increasing Overlap? Curr Oncol Rep 2019;21. [DOI: 10.1007/s11912-019-0796-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
414 Wun T, White RH. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest 2009;27 Suppl 1:63-74. [PMID: 19291526 DOI: 10.1080/07357900802656681] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
415 Gomes F, Descamps T, Lowe J, Little M, Lauste R, Krebs MG, Graham D, Thistlethwaite F, Carter L, Cook N. Enrolment of older adults with cancer in early phase clinical trials-an observational study on the experience in the north west of England. Age Ageing 2021:afab091. [PMID: 34107012 DOI: 10.1093/ageing/afab091] [Reference Citation Analysis]
416 Noble F, Curtis N, Harris S, Kelly JJ, Bailey IS, Byrne JP, Underwood TJ; South Coast Cancer Collaboration–Oesophago-Gastric (SC-OG). Risk assessment using a novel score to predict anastomotic leak and major complications after oesophageal resection. J Gastrointest Surg 2012;16:1083-95. [PMID: 22419007 DOI: 10.1007/s11605-012-1867-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
417 Chiang LY, Liu J, Flood KL, Carroll MB, Piccirillo JF, Stark S, Wang A, Wildes TM. Geriatric assessment as predictors of hospital readmission in older adults with cancer. J Geriatr Oncol 2015;6:254-61. [PMID: 25976445 DOI: 10.1016/j.jgo.2015.04.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
418 Ambatipudi S, Langdon R, Richmond RC, Suderman M, Koestler DC, Kelsey KT, Kazmi N, Penfold C, Ho KM, McArdle W, Ring SM, Pring M, Waterboer T, Pawlita M, Gaunt TR, Davey Smith G, Thomas S, Ness AR, Relton CL. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival. Oral Oncol 2018;85:87-94. [PMID: 30220325 DOI: 10.1016/j.oraloncology.2018.08.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
419 Backs D, Saglam I, Löffler C, Ihne S, Morbach C, Brenner S, Angermann C, Ertl G, Frantz S, Störk S, Knop S, Güder G. Prevalence of cardiovascular risk factors and diseases in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Oncotarget 2019;10:3154-65. [PMID: 31139330 DOI: 10.18632/oncotarget.26872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
420 Yang Y, Li HY, Zhou Q, Peng ZW, An X, Li W, Xiong LP, Yu XQ, Jiang WQ, Mao HP. Renal Function and All-Cause Mortality Risk Among Cancer Patients. Medicine (Baltimore) 2016;95:e3728. [PMID: 27196494 DOI: 10.1097/MD.0000000000003728] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 5.8] [Reference Citation Analysis]
421 Stordeur S, Schillemans V, Savoye I, Vanschoenbeek K, Leroy R, Macq G, Verleye L, De Gendt C, Nuyts S, Vermorken J, Beguin C, Grégoire V, Van Eycken L. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? Oral Oncol 2020;102:104561. [PMID: 31918175 DOI: 10.1016/j.oraloncology.2019.104561] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
422 Tangjitgamol S, Khunnarong J, Srijaipracharoen S. Medical Morbidities in Endometrial Cancer Patients: . International Journal of Gynecological Cancer 2014;24:1623-7. [DOI: 10.1097/igc.0000000000000291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Saeed S, Khan JA, Iqbal N, Irfan S, Shafique A, Awan S. Cancer and how the patients see it; prevalence and perception of risk factors: a cross-sectional survey from a tertiary care centre of Karachi, Pakistan. BMC Public Health 2019;19:360. [PMID: 30935404 DOI: 10.1186/s12889-019-6667-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
424 Velasco E, Bigni R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Microbiol Infect Dis 2008;27:1071-8. [DOI: 10.1007/s10096-008-0546-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
425 Jing W, Guo H, Kong L, Zhang Y, Wang H, An C, Zhu H, Yu J. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute. Medicine (Baltimore) 2016;95:e5630. [PMID: 27977606 DOI: 10.1097/MD.0000000000005630] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
426 Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, van der Velden LA, Lacko M, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. Feasibility of an eHealth application "OncoKompas" to improve personalized survivorship cancer care. Support Care Cancer 2016;24:2163-71. [PMID: 26563178 DOI: 10.1007/s00520-015-3004-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 10.2] [Reference Citation Analysis]
427 Miyamoto DT, Mamon HJ, Ryan DP, Willett CG, Ancukiewicz M, Kobayashi WK, Blaszkowsky L, Fernandez-del Castillo C, Hong TS. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older. Int J Radiat Oncol Biol Phys. 2010;77:1171-1177. [PMID: 19800182 DOI: 10.1016/j.ijrobp.2009.06.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
428 VanderWalde NA, Fleming M, Weiss J, Chera BS. Treatment of older patients with head and neck cancer: a review. Oncologist 2013;18:568-78. [PMID: 23635557 DOI: 10.1634/theoncologist.2012-0427] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
429 Rinkel R, Verdonck-de Leeuw I, van den Brakel N, de Bree R, Eerenstein S, Aaronson N, Leemans C. Patient-reported symptom questionnaires in laryngeal cancer: Voice, speech and swallowing. Oral Oncology 2014;50:759-64. [DOI: 10.1016/j.oraloncology.2014.05.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
430 Lee BS, Hwang JH, Lee SH, Jang SE, Ahn DW, Hwang DW, Cho JY, Yoon YS, Han HS, Ahn S. Older adults with biliary tract cancer: treatment and prognosis. J Am Geriatr Soc 2012;60:1862-71. [PMID: 23035728 DOI: 10.1111/j.1532-5415.2012.04163.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
431 Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, Fuchs CS. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009;169:2102-2108. [PMID: 20008694 DOI: 10.1001/archinternmed.2009.412] [Cited by in Crossref: 182] [Cited by in F6Publishing: 146] [Article Influence: 16.5] [Reference Citation Analysis]
432 Ghebre RG, Posthuma R, Vogel RI, Geller MA, Carson LF. Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer. Gynecol Oncol 2011;121:595-9. [PMID: 21402401 DOI: 10.1016/j.ygyno.2011.02.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
433 Paleri V, Wight RG, Silver CE, Haigentz M, Takes RP, Bradley PJ, Rinaldo A, Sanabria A, Bień S, Ferlito A. Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice. Oral Oncology 2010;46:712-9. [DOI: 10.1016/j.oraloncology.2010.07.008] [Cited by in Crossref: 148] [Cited by in F6Publishing: 120] [Article Influence: 13.5] [Reference Citation Analysis]
434 Ahn DH, Mehta N, Yorio JT, Xie Y, Yan J, Gerber DE. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer. Clin Lung Cancer 2013;14:644-50. [PMID: 23886797 DOI: 10.1016/j.cllc.2013.06.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
435 Mak RH, Mamon HJ, Ryan DP, Miyamoto DT, Ancukiewicz M, Kobayashi WK, Willett CG, Choi NC, Blaszkowsky LS, Hong TS. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older: ChemoRT, esophageal cancer in the elderly. Diseases of the Esophagus 2010;23:316-23. [DOI: 10.1111/j.1442-2050.2009.01014.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
436 Hall SF, Irish JC, Gregg RW, Groome PA, Rohland S. Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer. Curr Oncol 2015;22:e61-8. [PMID: 25908922 DOI: 10.3747/co.22.2235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
437 van der Kamp MF, Muntinghe FOW, Iepsma RS, Plaat BEC, van der Laan BFAM, Algassab A, Steenbakkers RJHM, Witjes MJH, van Dijk BAC, de Bock GH, Halmos GB. Predictors for distant metastasis in head and neck cancer, with emphasis on age. Eur Arch Otorhinolaryngol 2021;278:181-90. [PMID: 32542417 DOI: 10.1007/s00405-020-06118-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
438 Ou P, Gear K, Rahnama F, Thomas S, Nagappan R, Kee D, Waldvogel-thurlow S, Jain R, Mcivor N, Izzard M, Douglas R. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study: HPV and OPSCC. ANZ Journal of Surgery 2018;88:E278-83. [DOI: 10.1111/ans.13759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
439 Lund JL, Stürmer T, Sanoff HK, Brookhart A, Sandler RS, Warren JL. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients. Cancer 2013;119:2038-47. [PMID: 23512326 DOI: 10.1002/cncr.27991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
440 Alibhai SM, Horgan AM. Cancer screening in older adults: What to do when we don't know. Journal of Geriatric Oncology 2011;2:149-60. [DOI: 10.1016/j.jgo.2011.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
441 Mes SW, van Velden FHP, Peltenburg B, Peeters CFW, Te Beest DE, van de Wiel MA, Mekke J, Mulder DC, Martens RM, Castelijns JA, Pameijer FA, de Bree R, Boellaard R, Leemans CR, Brakenhoff RH, de Graaf P. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures. Eur Radiol 2020;30:6311-21. [PMID: 32500196 DOI: 10.1007/s00330-020-06962-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
442 Barrett TF, Mazul AL, Stepan KO, Wood CB, Paniello RC, Zevallos JP, Massa S, Jackson RS, Schmitt NC, Zenga J, Kang SY, Pipkorn P, Rich JT, Puram SV. The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database. Oral Oncol 2021;118:105330. [PMID: 33991757 DOI: 10.1016/j.oraloncology.2021.105330] [Reference Citation Analysis]
443 Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW, Stephenson AJ. Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era. Journal of Urology 2012;187:1259-65. [DOI: 10.1016/j.juro.2011.11.084] [Cited by in Crossref: 89] [Cited by in F6Publishing: 67] [Article Influence: 9.9] [Reference Citation Analysis]
444 Sinha P, Wong AWK, Kallogjeri D, Piccirillo JF. Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox. JAMA Otolaryngol Head Neck Surg 2018;144:978-87. [PMID: 29710116 DOI: 10.1001/jamaoto.2018.0283] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
445 Ha MS, Chang IH. Significance of age and comorbidity as prognostic indicators for patients with bladder cancer. Asian J Androl 2010;12:766-74. [PMID: 20676116 DOI: 10.1038/aja.2010.29] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
446 L'Esperance HE, Kallogjeri D, Yousaf S, Piccirillo JF, Rich JT. Prediction of mortality and morbidity in head and neck cancer patients 80 years of age and older undergoing surgery. Laryngoscope 2018;128:871-7. [PMID: 29105781 DOI: 10.1002/lary.26858] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
447 Kawakubo K, Tada M, Isayama H, Sasahira N, Nakai Y, Takahara N, Miyabayashi K, Yamamoto K, Mizuno S, Mohri D, Kogure H, Sasaki T, Yamamoto N, Tateishi R, Hirano K, Ijichi H, Tateishi K, Koike K. Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2013;42:687-691. [PMID: 23211374 DOI: 10.1097/mpa.0b013e318270ea97] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
448 Strojnik K, Mahkovic-Hergouth K, Novakovic BJ, Seruga B. Outcome of severe infections in afebrile neutropenic cancer patients. Radiol Oncol 2016;50:442-8. [PMID: 27904453 DOI: 10.1515/raon-2016-0011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
449 Ankola AA, Smith RV, Burk RD, Prystowsky MB, Sarta C, Schlecht NF. Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population. Oral Oncol 2013;49:911-7. [PMID: 23891528 DOI: 10.1016/j.oraloncology.2013.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
450 Zolbanin HM, Delen D, Hassan Zadeh A. Predicting overall survivability in comorbidity of cancers: A data mining approach. Decision Support Systems 2015;74:150-61. [DOI: 10.1016/j.dss.2015.04.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 9.2] [Reference Citation Analysis]
451 Nugent EK, Brooks RA, Barr CD, Case AS, Mutch DG, Massad LS. Clinical and Pathologic Features of Vulvar Intraepithelial Neoplasia in Premenopausal and Postmenopausal Women. Journal of Lower Genital Tract Disease 2011;15:15-9. [DOI: 10.1097/lgt.0b013e3181ee2598] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
452 Datema FR, Poldermans D, Baatenburg de Jong RJ. Incidence and prediction of major cardiovascular complications in head and neck surgery. Head Neck 2010;32:1485-93. [DOI: 10.1002/hed.21351] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
453 Blaes A, Prizment A, Koene RJ, Konety S. Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease. Heart Fail Clin 2017;13:367-80. [PMID: 28279422 DOI: 10.1016/j.hfc.2016.12.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
454 Lee SH, Choi HC, Jeong SH, Lee KH, Chung JI, Park YS, Hwang JH, Kim JW, Kim N, Lee DH. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival. J Am Geriatr Soc. 2011;59:241-250. [PMID: 21275934 DOI: 10.1111/j.1532-5415.2010.03273.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
455 Calvo-Espinos C, De Gaona-Lana ER, Gonzalez-Anguren C, Lama-Gay M. Assessment of the impact of comorbidity on the survival of cancer patients treated by palliative care teams. Palliat Support Care 2015;13:1049-55. [PMID: 26165849 DOI: 10.1017/S1478951514000832] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
456 Ghanem A, Modh A, Burmeister C, Munkarah A, Elshaikh M. Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer? Gynecol Obstet Invest 2018;83:290-8. [DOI: 10.1159/000487047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
457 Nardi R, Scanelli G, Corrao S, Iori I, Mathieu G, Cataldi Amatrian R. Co-morbidity does not reflect complexity in internal medicine patients. European Journal of Internal Medicine 2007;18:359-68. [DOI: 10.1016/j.ejim.2007.05.002] [Cited by in Crossref: 67] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
458 Raine R, Wallace I, Nic a’ Bháird C, Xanthopoulou P, Lanceley A, Clarke A, Prentice A, Ardron D, Harris M, Gibbs JSR, Ferlie E, King M, Blazeby JM, Michie S, Livingston G, Barber J. Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study. Health Services and Delivery Research 2014;2:1-172. [DOI: 10.3310/hsdr02370] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
459 Soares M, Darmon M, Salluh JI, Ferreira CG, Thiéry G, Schlemmer B, Spector N, Azoulay E. Prognosis of lung cancer patients with life-threatening complications. Chest. 2007;131:840-846. [PMID: 17356101 DOI: 10.1378/chest.06-2244] [Cited by in Crossref: 90] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
460 Polednak AP. Prevalence and predictors of comorbid diabetes among newly diagnosed Hispanic cancer patients in Connecticut. Cancer Detection and Prevention 2007;31:453-6. [DOI: 10.1016/j.cdp.2007.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
461 Zhang LP, Ren H, Du YX, Zheng XH, Zhang ZM, Wang CF. Combination of preoperative fibrinogen and D-dimer as a prognostic indicator in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastrointest Surg 2021;13:279-302. [PMID: 33796216 DOI: 10.4240/wjgs.v13.i3.279] [Reference Citation Analysis]
462 Cai S, Hong TS, Goldberg SI, Fernandez-del Castillo C, Thayer SP, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Willett CG, Lillemoe KD, Warshaw AL, Wo JY. Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010. Cancer 2013;119:4196-204. [PMID: 24006012 DOI: 10.1002/cncr.28329] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
463 Chandra RA, Chen MH, Zhang D, Loffredo M, D'Amico AV. Evidence suggesting that obesity prevention measures may improve prostate cancer outcomes using data from a prospective randomized trial. Prostate Cancer 2014;2014:478983. [PMID: 24693436 DOI: 10.1155/2014/478983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
464 Dobbins TA, Creighton N, Currow DC, Young JM. Look back for the Charlson Index did not improve risk adjustment of cancer surgical outcomes. Journal of Clinical Epidemiology 2015;68:379-86. [DOI: 10.1016/j.jclinepi.2014.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
465 Jin YN, Zhang WJ, Cai XY, Li MS, Lawrence WR, Wang SY, Mai DM, Du YY, Luo DH, Mo HY. The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era. Cancer Res Treat 2019;51:34-42. [PMID: 29409313 DOI: 10.4143/crt.2017.551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
466 Tsai J, Abe K, Boulet SL, Beckman MG, Hooper WC, Grant AM. Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism. PLoS One 2013;8:e70061. [PMID: 23922902 DOI: 10.1371/journal.pone.0070061] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
467 Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, Gill I, Graham D, Huang W, Jewett MA, Latcha S, Lowrance W, Rosner M, Shayegan B, Thompson RH, Uzzo R, Russo P. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2017;35:668-80. [PMID: 28095147 DOI: 10.1200/JCO.2016.69.9645] [Cited by in Crossref: 159] [Cited by in F6Publishing: 29] [Article Influence: 39.8] [Reference Citation Analysis]
468 Abi Aad S, Pierce M, Barmaimon G, Farhat FS, Benjo A, Mouhayar E. Hypertension induced by chemotherapeutic and immunosuppresive agents: a new challenge. Crit Rev Oncol Hematol 2015;93:28-35. [PMID: 25217090 DOI: 10.1016/j.critrevonc.2014.08.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
469 Courant M, Orazio S, Monnereau A, Preterre J, Combe C, Rigothier C. Incidence, prognostic impact and clinical outcomes of renal impairment in patients with multiple myeloma: a population-based registry. Nephrology Dialysis Transplantation 2021;36:482-90. [DOI: 10.1093/ndt/gfz211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
470 Jacobs DHM, Charaghvandi RK, Horeweg N, Maduro JH, Speijer G, Roeloffzen EMA, Mast M, Bantema-Joppe E, Petoukhova AL, van den Bongard DHJG, Koper P, Crijns APG, Marijnen CAM, Verkooijen HM. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens. Breast Cancer Res Treat 2021;189:387-98. [PMID: 34216316 DOI: 10.1007/s10549-021-06314-4] [Reference Citation Analysis]
471 Pallis A, Ring A, Fortpied C, Penninckx B, Van Nes M, Wedding U, vonMinckwitz G, Johnson C, Wyld L, Timmer-bonte A, Bonnetain F, Repetto L, Aapro M, Luciani A, Wildiers H. EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Annals of Oncology 2011;22:1922-6. [DOI: 10.1093/annonc/mdq687] [Cited by in Crossref: 104] [Cited by in F6Publishing: 69] [Article Influence: 10.4] [Reference Citation Analysis]
472 Paulino Pereira NR, Beks RB, Janssen SJ, Harris MB, Hornicek FJ, Ferrone ML, Schwab JH. Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases? The Spine Journal 2016;16:951-61. [DOI: 10.1016/j.spinee.2016.03.043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
473 Ngo-Huang A, Holmes HM, des Bordes JKA, Parker NH, Fogelman D, Petzel MQB, Song J, Bruera E, Katz MHG. Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma. Cancer Med 2019;8:2867-76. [PMID: 31033241 DOI: 10.1002/cam4.2157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
474 Peterson LA, Bellile EL, Wolf GT, Virani S, Shuman AG, Taylor JM, Rozek LS; University of Michigan Head and Neck Specialized Program of Research Excellence Program. Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population. Head Neck 2016;38:1810-20. [PMID: 27432208 DOI: 10.1002/hed.24515] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
475 Sierink J, de Castro S, Russell N, Geenen M, Steller E, Vrouenraets B. Treatment strategies in elderly breast cancer patients: Is there a need for surgery? The Breast 2014;23:793-8. [DOI: 10.1016/j.breast.2014.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
476 Yang Y, Li ZL, Wang FM, Tang RN, Tu Y, Liu H. MicroRNA26a inhibits cisplatin-induced renal tubular epithelial cells apoptosis through suppressing the expression of transient receptor potential channel 6 mediated dynamin-related protein 1. Cell Biochem Funct 2020;38:384-91. [PMID: 31887787 DOI: 10.1002/cbf.3474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
477 van der Schroeff MP, Steyerberg EW, Wieringa MH, Langeveld TPM, Molenaar J, Baatenburg de Jong RJ. Prognosis: A variable parameter. Dynamic prognostic modeling in head and neck squamous cell carcinoma. Head Neck 2012;34:34-41. [DOI: 10.1002/hed.21693] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
478 Lee EH, Nijhawan RI, Nehal KS, Dusza SW, Levine A, Hill A, Barker CA. Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire. J Skin Cancer 2015;2015:953479. [PMID: 26180643 DOI: 10.1155/2015/953479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
479 D'amico AV. Statin Use and the Risk of Prostate-Specific Antigen Recurrence After Radiation Therapy With or Without Hormone Therapy for Prostate Cancer. JCO 2010;28:2651-2. [DOI: 10.1200/jco.2010.28.5809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
480 Sitlinger A, Shelby RA, Van Denburg AN, White H, Edmond SN, Marcom PK, Bosworth HB, Keefe FJ, Kimmick GG. Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer. J Geriatr Oncol 2019;10:317-21. [PMID: 30553719 DOI: 10.1016/j.jgo.2018.11.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
481 Polednak AP. Obtaining smoking histories for population-based studies on multiple primary cancers: Connecticut, 2002. Int J Cancer 2006;119:233-5. [PMID: 16432840 DOI: 10.1002/ijc.21786] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
482 Van Abel KM, Routman DM, Moore EJ, Ma DJ, Yin LX, Fields PA, Schofield M, Bartemes KR, Chatzopoulos K, Price DL, Janus JR, Kasperbauer JL, Price KA, Chintakuntlawar AV, Neben-Wittich MA, Foote RL, Garcia JJ. T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma. Oral Oncol 2020;111:104894. [PMID: 32712575 DOI: 10.1016/j.oraloncology.2020.104894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
483 Sarfati D. How Do We Measure Comorbidity? In: Koczwara B, editor. Cancer and Chronic Conditions. Singapore: Springer; 2016. pp. 35-70. [DOI: 10.1007/978-981-10-1844-2_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
484 Bryant AK, Sojourner EJ, Vitzthum LK, Zakeri K, Shen H, Nguyen C, Murphy JD, Califano JA, Cohen EEW, Mell LK. Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer. J Natl Cancer Inst. 2018;110:1393-1399. [PMID: 29878161 DOI: 10.1093/jnci/djy072] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
485 Mamtani R, Wang XV, Gyawali B, DiPaola RS, Epperson CN, Haas NB, Dutcher JP. Association between age and sex and mortality after adjuvant therapy for renal cancer. Cancer 2019;125:1637-44. [PMID: 30620389 DOI: 10.1002/cncr.31955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
486 Fiorica F, Cartei F, Carau B, Berretta S, Spartà D, Tirelli U, Santangelo A, Maugeri D, Luca S, Leotta C, Sorace R, Berretta M. Adjuvant radiotherapy on older and oldest elderly rectal cancer patients. Archives of Gerontology and Geriatrics 2009;49:54-9. [DOI: 10.1016/j.archger.2008.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
487 Fraeman KH, Nordstrom BL, Luo W, Landis SH, Shantakumar S. Incidence of new-onset hypertension in cancer patients: a retrospective cohort study. Int J Hypertens 2013;2013:379252. [PMID: 24455206 DOI: 10.1155/2013/379252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
488 Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL 3rd, Strope SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Kibel AS. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 2013;64:372-8. [PMID: 23506834 DOI: 10.1016/j.eururo.2013.03.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
489 Sabatino SA, Thompson TD, Wu XC, Fleming ST, Kimmick GG, Trentham-Dietz A, Cress R, Anderson RT. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer. Breast Cancer Res Treat 2014;146:199-209. [PMID: 24899083 DOI: 10.1007/s10549-014-2998-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
490 Antic D, Jelicic J, Trajkovic G, Balint MT, Bila J, Markovic O, Petkovic I, Nikolic V, Andjelic B, Djurasinovic V, Sretenovic A, Smiljanic M, Vukovic V, Mihaljevic B. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities. Ann Hematol 2018;97:267-76. [PMID: 29130134 DOI: 10.1007/s00277-017-3170-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
491 Zhao Z, Huang X, Gu T, Chen Z, Gan L, Zhu B, Wu N. Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal. Gastroenterol Res Pract 2021;2021:5595718. [PMID: 33883995 DOI: 10.1155/2021/5595718] [Reference Citation Analysis]
492 D'Amico AV, Chen MH, Renshaw AA, Loffredo B, Kantoff PW. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. J Clin Oncol 2008;26:2979-83. [PMID: 18565884 DOI: 10.1200/JCO.2007.15.9699] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
493 Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol 2013;5:3-29. [PMID: 24227920 DOI: 10.2147/CLEP.S47150] [Cited by in Crossref: 268] [Cited by in F6Publishing: 120] [Article Influence: 33.5] [Reference Citation Analysis]
494 Quinten C, Coens C, Ghislain I, Zikos E, Sprangers MA, Ringash J, Martinelli F, Ediebah DE, Maringwa J, Reeve BB, Greimel E, King MT, Bjordal K, Flechtner H, Schmucker-von Koch J, Taphoorn MJ, Weis J, Wildiers H, Velikova G, Bottomley A. The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. European Journal of Cancer 2015;51:2808-19. [DOI: 10.1016/j.ejca.2015.08.027] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
495 Pozo G, Pérez-Escutia MA, Ruíz A, Ferrando A, Milanés A, Cabello E, Díaz R, Prado A, Pérez-Regadera JF. Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites. Rep Pract Oncol Radiother 2019;24:239-44. [PMID: 30858768 DOI: 10.1016/j.rpor.2019.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
496 Zhao L, Leung LH, Wang J, Li H, Che J, Liu L, Yao X, Cao B. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer. BMC Pulm Med 2017;17:112. [PMID: 28806935 DOI: 10.1186/s12890-017-0452-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
497 O’Malley CD, Shema SJ, Cress RD, Bauer K, Kahn AR, Schymura MJ, Wike JM, Stewart SL. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study. J Womens Health (Larchmt). 2012;21:887-894. [PMID: 22816528 DOI: 10.1089/jwh.2012.3781] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
498 Imperatori A, Harrison RN, Dominioni L, Leitch N, Nardecchia E, Jeebun V, Brown J, Altieri E, Castiglioni M, Cattoni M, Rotolo N. Resection rate of lung cancer in Teesside (UK) and Varese (Italy): a comparison after implementation of the National Cancer Plan. Thorax 2016;71:230-7. [PMID: 26612687 DOI: 10.1136/thoraxjnl-2015-207572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
499 Piccirillo JF, Vlahiotis A. Comorbidity in patients with cancer of the head and neck: Prevalence and impact on treatment and prognosis. Curr Oncol Rep 2006;8:123-9. [DOI: 10.1007/s11912-006-0047-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
500 Michalopoulou E, Matthes KL, Karavasiloglou N, Wanner M, Limam M, Korol D, Held L, Rohrmann S. Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study. Cancer Epidemiol 2021;73:101962. [PMID: 34051687 DOI: 10.1016/j.canep.2021.101962] [Reference Citation Analysis]
501 Sorror ML, Storer B, Storb RF. Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences. Biol Blood Marrow Transplant 2009;15:757-8. [PMID: 19450761 DOI: 10.1016/j.bbmt.2009.02.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
502 O'Hare M, Sharma A, Murphy K, Mookadam F, Lee H. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity. Expert Rev Cardiovasc Ther 2015;13:511-8. [PMID: 25843285 DOI: 10.1586/14779072.2015.1032940] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
503 Janssen-Heijnen ML, van Spronsen DJ, Lemmens VE, Houterman S, Verheij KD, Coebergh JW. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol 2005;129:597-606. [PMID: 15916681 DOI: 10.1111/j.1365-2141.2005.05508.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
504 Della Porta MG, Malcovati L. Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome. Haematologica 2009;94:602-6. [PMID: 19407314 DOI: 10.3324/haematol.2009.005702] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
505 Sarfati D, Gurney J, Lim BT, Bagheri N, Simpson A, Koea J, Dennett E. Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival. Asia Pac J Clin Oncol. 2013;Epub ahead of print. [PMID: 24354451 DOI: 10.1111/ajco.12130] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
506 Ryu J, Lee H. Effects of Comorbidity and Smoking on the Survival of Lung Cancer Patients. JCO 2006;24:5468-9. [DOI: 10.1200/jco.2006.08.4004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
507 Jeong SS, Choi PJ, Yi JH, Yoon SS. Impact of Lifestyle Diseases on Postoperative Complications and Survival in Elderly Patients with Stage I Non-Small Cell Lung Cancer. Korean J Thorac Cardiovasc Surg 2017;50:86-93. [PMID: 28382266 DOI: 10.5090/kjtcs.2017.50.2.86] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
508 Hurria A. Embracing the Complexity of Comorbidity. JCO 2011;29:4217-8. [DOI: 10.1200/jco.2011.37.5717] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
509 Bras L, de Vries J, Festen S, Steenbakkers RJHM, Langendijk JA, Witjes MJH, van der Laan BFAM, de Bock GH, Halmos GB. Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: A prospective study. Oral Oncol 2021;118:105329. [PMID: 34111770 DOI: 10.1016/j.oraloncology.2021.105329] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Rubens M, Appunni S, Ramamoorthy V, Saxena A, Das S, Bhatt C, Boulanger BK, Viamonte-ros A, Veledar E. Prevalence of Cardiovascular Risk Factors Among Cancer Patients in the United States. Metabolic Syndrome and Related Disorders 2019;17:397-405. [DOI: 10.1089/met.2018.0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
511 Janssen-Heijnen ML, Lemmens VE, van den Borne BE, Biesma B, Oei SB, Coebergh JW. Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: a population-based study in the Netherlands. Crit Rev Oncol Hematol 2007;62:172-8. [PMID: 17197191 DOI: 10.1016/j.critrevonc.2006.11.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
512 Lowenstein LM, Mohile SG, Gil HH, Pandya C, Hemmerich J, Rodin M, Dale W. Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study. J Geriatr Oncol 2016;7:437-43. [PMID: 27480793 DOI: 10.1016/j.jgo.2016.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
513 Williams SB, Kamat AM, Chamie K, Froehner M, Wirth MP, Wiklund PN, Black PC, Steinberg GD, Boorjian SA, Daneshmand S, Goebell PJ, Pohar KS, Shariat SF, Thalmann GN. Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. Eur Urol Oncol 2018;1:91-100. [PMID: 30345422 DOI: 10.1016/j.euo.2018.03.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
514 Nepple KG, Strope SA, Grubb RL 3rd, Kibel AS. Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer. Urol Oncol 2013;31:894-8. [PMID: 21803615 DOI: 10.1016/j.urolonc.2011.06.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
515 Kulaylat AN, Schubart JR, Schaefer EW, Hollenbeak CS, Cooper AB, Gusani NJ. Costs of hepato-pancreato-biliary surgery and readmissions in privately insured US patients. J Surg Res 2015;199:478-86. [PMID: 26026853 DOI: 10.1016/j.jss.2015.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
516 Möhl A, Orban E, Jung AY, Behrens S, Obi N, Chang-Claude J, Becher H. Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study. Cancer 2021;127:1154-60. [PMID: 33259052 DOI: 10.1002/cncr.33363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
517 Sinha P, Hackman T, Nussenbaum B, Wu N, Lewis JS Jr, Haughey BH. Transoral laser microsurgery for oral squamous cell carcinoma: oncologic outcomes and prognostic factors. Head Neck 2014;36:340-51. [PMID: 23729304 DOI: 10.1002/hed.23293] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
518 Luo X, Sturgis EM, Yang Z, Sun Y, Wei P, Liu Z, Wei Q, Li G. Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy. Carcinogenesis 2019;40:735-41. [PMID: 30721961 DOI: 10.1093/carcin/bgz019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
519 Morris AM. Putting the Integration Into Integrated Health Care Systems. JCO 2015;33:821-2. [DOI: 10.1200/jco.2014.59.6015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
520 Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, Forsythe LP, Rowland JH. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 2015;9:239-51. [DOI: 10.1007/s11764-014-0403-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 15.1] [Reference Citation Analysis]
521 Okuyemi OT, Dwivedi RC, Kazi R, Piccirillo JF. Significance of comorbidity in cancers of the head and neck region. J Chin Med Assoc 2010;73:507-8. [PMID: 21051024 DOI: 10.1016/S1726-4901(10)70109-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
522 Zbar AP, Gravitz A, Audisio RA. Principles of surgical oncology in the elderly. Clin Geriatr Med. 2012;28:51-71. [PMID: 22326035 DOI: 10.1016/j.cger.2011.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
523 Ben-Ami E, Merom H, Sikron F, Livneh J, Sadetzki S, Wolf I. Involvement of the family physician in the care of chemotherapy-treated patients with cancer: patients' perspectives. J Oncol Pract 2014;10:298-305. [PMID: 24781366 DOI: 10.1200/JOP.2013.001182] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
524 Fleming ST, Sabatino SA, Kimmick G, Cress R, Wu XC, Trentham-Dietz A, Huang B, Hwang W, Liff J. Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review. Med Care 2011;49:752-60. [PMID: 21490514 DOI: 10.1097/MLR.0b013e318215d7dd] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
525 Janssen-heijnen M, Maas H, van de Schans S, Coebergh J, Groen H. Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it? Annals of Oncology 2011;22:821-6. [DOI: 10.1093/annonc/mdq448] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
526 Wei F. Does an extreme age (≥80 years) affect outcomes in patients after liver cancer surgery? A meta-analysis. ANZ J Surg 2019;89:25-31. [PMID: 29885205 DOI: 10.1111/ans.14676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
527 Grose D, Milroy R. Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer. J Comorb 2011;1:45-50. [PMID: 29090135 DOI: 10.15256/joc.2011.1.5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
528 Parekh A, Chen M, D’amico AV, Dosoretz DE, Ross R, Salenius S, Graham PL, Beckman JA, Beard CJ, Choueiri TK, Ennis RD, Hoffman KE, Hu JC, Ma J, Martin NE, Nguyen PL. Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy 2013;12:415-21. [DOI: 10.1016/j.brachy.2013.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
529 Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA, Oxnard GR. Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer. JAMA Oncol 2016;2:313-20. [PMID: 26720421 DOI: 10.1001/jamaoncol.2015.4482] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 14.8] [Reference Citation Analysis]
530 Arends CR, Petersen JF, van der Noort V, Timmermans AJ, Leemans CR, de Bree R, van den Brekel MWM, Stuiver MM. Optimizing Survival Predictions of Hypopharynx Cancer: Development of a Clinical Prediction Model. Laryngoscope 2020;130:2166-72. [PMID: 31693181 DOI: 10.1002/lary.28345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
531 Egleston BL, Uzzo RG, Beck JR, Wong YN. A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures. Health Serv Res 2015;50:1179-94. [PMID: 25523400 DOI: 10.1111/1475-6773.12276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
532 Overgaard J. Chemoradiotherapy of head and neck cancer – Can the bumble bee fly? Radiotherapy and Oncology 2009;92:1-3. [DOI: 10.1016/j.radonc.2009.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
533 Garrana SH, Dagogo-Jack I, Cobb R, Kuo AH, Mendoza DP, Zhang EW, Heeger A, Sequist LV, Digumarthy SR. Clinical and Imaging Features of Non-Small-Cell Lung Cancer in Young Patients. Clin Lung Cancer 2021;22:23-31. [PMID: 33189594 DOI: 10.1016/j.cllc.2020.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
534 Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MHG. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 2017;21:155-63. [DOI: 10.1007/s11605-016-3270-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
535 De Felice F, Musio D, Izzo L, Pugliese F, Izzo P, Bolognese A, Tombolini V. Preoperative chemoradiotherapy in elderly patients with locally advanced rectal cancer. Biomed Res Int 2013;2013:610786. [PMID: 24392453 DOI: 10.1155/2013/610786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
536 Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011;29:3620-7. [PMID: 21859998 DOI: 10.1200/JCO.2010.32.0796] [Cited by in Crossref: 128] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
537 Wong Doo N, White VM, Martin K, Bassett JK, Prince HM, Harrison SJ, Jefford M, Winship I, Millar JL, Milne RL, Seymour JF, Giles GG. The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment. Cancers (Basel) 2019;11:E928. [PMID: 31269764 DOI: 10.3390/cancers11070928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
538 Penfold CM, Thomas SJ, Waylen A, Ness AR. Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from Head and Neck 5000. Head Neck 2018;40:1389-99. [PMID: 29485685 DOI: 10.1002/hed.25116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
539 Joice GA, Deibert CM, Kates M, Spencer BA, Mckiernan JM. “Never Events”: Centers for Medicare and Medicaid Services Complications After Radical Cystectomy. Urology 2013;81:527-32. [DOI: 10.1016/j.urology.2012.09.050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
540 Siddiqui F, Gwede CK. Head and Neck Cancer in the Elderly Population. Seminars in Radiation Oncology 2012;22:321-33. [DOI: 10.1016/j.semradonc.2012.05.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
541 Hall SF, Groome PA, Irish J, O'sullivan B. Radiotherapy or surgery for head and neck squamous cell cancer: Establishing the baseline for hypopharyngeal carcinoma? Cancer 2009;115:5711-22. [DOI: 10.1002/cncr.24635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
542 Strevel EL, Siu LL. Cardiovascular toxicity of molecularly targeted agents. European Journal of Cancer 2009;45:318-31. [DOI: 10.1016/s0959-8049(09)70046-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
543 Sinha P, Kallogjeri D, Piccirillo JF. Assessment of comorbidities in surgical oncology outcomes: Comorbidity in Surgical Oncology. J Surg Oncol 2014;110:629-35. [DOI: 10.1002/jso.23723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
544 Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS, Morrow M, Gemignani ML. Predictors of Completion Axillary Lymph Node Dissection in Patients With Immunohistochemical Metastases to the Sentinel Lymph Node in Breast Cancer. Ann Surg Oncol 2010;17:1063-8. [DOI: 10.1245/s10434-009-0834-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
545 van Gestel YR, Lemmens VE, de Hingh IH, Steevens J, Rutten HJ, Nieuwenhuijzen GA, van Dam RM, Siersema PD. Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients. Ann Surg Oncol. 2013;20:371-380. [PMID: 22987098 DOI: 10.1245/s10434-012-2663-1] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
546 Loupatatzi A, Stavrianos SD, Karantonis FF, Machairas A, Rapidis AD, Kokkalis G, Papadopoulos O. Are Females Predisposed to Complications in Head and Neck Cancer Free Flap Reconstruction? Journal of Oral and Maxillofacial Surgery 2014;72:178-85. [DOI: 10.1016/j.joms.2013.05.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
547 Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM. Comorbidity as a Mediator of Survival Disparity Between Younger and Older Women Diagnosed With Metastatic Breast Cancer. Hypertension 2012;59:205-11. [DOI: 10.1161/hypertensionaha.111.171736] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
548 Goede V, Cramer P, Busch R, Bergmann M, Stauch M, Hopfinger G, Stilgenbauer S, Döhner H, Westermann A, Wendtner CM, Eichhorst B, Hallek M; German CLL Study Group. Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials. Haematologica 2014;99:1095-100. [PMID: 24584349 DOI: 10.3324/haematol.2013.096792] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
549 Morris AM, Rhoads KF, Stain SC, Birkmeyer JD. Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg. 2010;211:105-113. [PMID: 20610256 DOI: 10.1016/j.jamcollsurg.2010.02.051] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 9.5] [Reference Citation Analysis]
550 Berger DA, Megwalu II, Vlahiotis A, Radwan MH, Serrano MF, Humphrey PA, Piccirillo JF, Kibel AS. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology 2008;72:359-63. [PMID: 18468663 DOI: 10.1016/j.urology.2008.02.061] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
551 Kase S, Baburin A, Kuddu M, Innos K. Incidence and Survival for Head and Neck Cancers in Estonia, 1996-2016: A Population-Based Study. Clin Epidemiol 2021;13:149-59. [PMID: 33658861 DOI: 10.2147/CLEP.S293929] [Reference Citation Analysis]
552 Kim MB, Chen MH, de Castro M, Loffredo M, Kantoff PW, D'Amico AV. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial. Cancer 2013;119:3280-6. [PMID: 23798006 DOI: 10.1002/cncr.28202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
553 Sharma A, Méndez E, Yueh B, Lohavanichbutr P, Houck J, Doody DR, Futran ND, Upton MP, Schwartz SM, Chen C. Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg 2012;146:739-45. [PMID: 22275190 DOI: 10.1177/0194599811434707] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
554 Harries I, Liang K, Williams M, Berlot B, Biglino G, Lancellotti P, Plana JC, Bucciarelli-Ducci C. Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review. JACC CardioOncol 2020;2:270-92. [PMID: 34396235 DOI: 10.1016/j.jaccao.2020.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
555 Keil F, Selzer E, Berghold A, Reinisch S, Kapp KS, De Vries A, Greil R, Bachtiary B, Tinchon C, Anderhuber W. Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck. Eur J Cancer. 2013;49:352-359. [PMID: 22981499 DOI: 10.1016/j.ejca.2012.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
556 Lee L, Cheung WY, Atkinson E, Krzyzanowska MK. Impact of Comorbidity on Chemotherapy Use and Outcomes in Solid Tumors: A Systematic Review. JCO 2011;29:106-17. [DOI: 10.1200/jco.2010.31.3049] [Cited by in Crossref: 121] [Cited by in F6Publishing: 63] [Article Influence: 12.1] [Reference Citation Analysis]
557 Ryoo JJ, Ordin DL, Antonio AL, Oishi SM, Gould MK, Asch SM, Malin JL. Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol 2013;31:2716-23. [PMID: 23752110 DOI: 10.1200/JCO.2012.45.7473] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
558 Tuchman SA, Shapiro GR, Ershler WB, Badros A, Cohen HJ, Dispenzieri A, Flores IQ, Kanapuru B, Jurivich D, Longo DL, Nourbakhsh A, Palumbo A, Walston J, Yates JW. Multiple myeloma in the very old: an IASIA conference report. J Natl Cancer Inst 2014;106:dju067. [PMID: 24700806 DOI: 10.1093/jnci/dju067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
559 Palomo L, Rubio C, Gérvas J. [The comorbidity in primary care]. Gac Sanit 2006;20 Suppl 1:182-91. [PMID: 16539981 DOI: 10.1157/13086042] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
560 Jonna S, Chiang L, Liu J, Carroll MB, Flood K, Wildes TM. Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer. Support Care Cancer 2016;24:4807-13. [PMID: 27465048 DOI: 10.1007/s00520-016-3334-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
561 Castro MA, Dedivitis RA, Ribeiro KC. Comorbidity Measurement in Patients with Laryngeal Squamous Cell Carcinoma. ORL 2007;69:146-52. [DOI: 10.1159/000099223] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
562 Mahal BA, Chen MH, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV. Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer-Specific Mortality. J Natl Compr Canc Netw 2018;16:727-34. [PMID: 29891524 DOI: 10.6004/jnccn.2018.7010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
563 Guo R, Mao YP, Chen L, Tang LL, Zhou GQ, Liu LZ, Tian L, Zeng MS, Jia WH, Shao JY, Lin AH, Ma J. Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma. Oncotarget 2017;8:10594-601. [PMID: 27070084 DOI: 10.18632/oncotarget.8621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
564 Offidani M, Corvatta L, Polloni C, Centurioni R, Visani G, Brunori M, Gentili S, Catarini M, Samori A, Blasi N, Alesiani F, Caraffa P, Burattini M, Galieni P, Fraticelli P, Ferranti M, Giuliodori L, Leoni P. Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. Clin Lymphoma Myeloma Leuk 2012;12:423-32. [PMID: 22981966 DOI: 10.1016/j.clml.2012.06.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
565 Anderson RT, Morris CR, Kimmick G, Trentham-Dietz A, Camacho F, Wu XC, Sabatino SA, Fleming ST, Lipscomb J. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors. Cancer 2015;121:790-9. [PMID: 25369150 DOI: 10.1002/cncr.29092] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
566 Farwell DG, Kezirian EJ, Heydt JL, Yueh B, Futran ND. Efficacy of small reconstruction plates in vascularized bone graft mandibular reconstruction. Head Neck 2006;28:573-9. [DOI: 10.1002/hed.20455] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
567 Brosens RP, Oomen JL, Glas AS, van Bochove A, Cuesta MA, Engel AF. POSSUM Predicts Decreased Overall Survival in Curative Resection for Colorectal Cancer. Diseases of the Colon & Rectum 2006;49:825-32. [DOI: 10.1007/s10350-005-0284-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
568 Sardaro A, McDonald F, Bardoscia L, Lavrenkov K, Singh S, Ashley S, Traish D, Ferrari C, Meattini I, Asabella AN, Brada M. Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study. Front Oncol 2020;10:594590. [PMID: 33425746 DOI: 10.3389/fonc.2020.594590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
569 Janssen-Heijnen MLG, van Erning FN, De Ruysscher DK, Coebergh JWW, Groen HJM. Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis. Ann Oncol 2015;26:902-7. [PMID: 25672893 DOI: 10.1093/annonc/mdv061] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
570 Hartmann S, Grandis JR. Treatment of head and neck cancer in the elderly. Expert Opinion on Pharmacotherapy 2016;17:1903-21. [DOI: 10.1080/14656566.2016.1220540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
571 van Dijk MR, Steyerberg EW, Habbema JD. A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patients. BMC Med Inform Decis Mak 2008;8:1. [PMID: 18171485 DOI: 10.1186/1472-6947-8-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
572 Fiorentino A, Caivano R, Chiumento C, Cozzolino M, Clemente S, Pedicini P, Fusco V. Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma. Med Oncol 2012;29:3467-71. [DOI: 10.1007/s12032-012-0246-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
573 Mayr R, Fritsche HM, Pycha A, Pycha A. Radical cystectomy and the implications of comorbidity. Expert Rev Anticancer Ther 2014;14:289-95. [PMID: 24397794 DOI: 10.1586/14737140.2014.868775] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
574 Di Genesio Pagliuca M, Perotti C, Apicella G, Galla A, Guffi M, Paolini M, Donis L, Amisano V, Torrente S, Manfredda I, Krengli M. Concurrent chemo-radiotherapy in elderly patients: tolerance and compliance in a series of 137 patients. Clin Transl Oncol 2016;18:571-5. [PMID: 26370422 DOI: 10.1007/s12094-015-1403-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
575 Wong ML, McMurry TL, Stukenborg GJ, Francescatti AB, Amato-Martz C, Schumacher JR, Chang GJ, Greenberg CC, Winchester DP, McKellar DP, Walter LC, Kozower BD. Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. Lung Cancer 2016;102:108-17. [PMID: 27987578 DOI: 10.1016/j.lungcan.2016.11.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
576 Bugter O, van Iwaarden DLP, van Leeuwen N, Nieboer D, Dronkers EAC, Hardillo JAU, Baatenburg de Jong RJ. A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study. Head Neck 2021;43:1881-9. [PMID: 33655596 DOI: 10.1002/hed.26666] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
577 Fotouhi B, Momeni N, Riolo MA, Buckeridge DL. Statistical methods for constructing disease comorbidity networks from longitudinal inpatient data. Appl Netw Sci 2018;3:46. [PMID: 30465022 DOI: 10.1007/s41109-018-0101-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
578 Marenco D, Marinello R, Berruti A, Gaspari F, Stasi M, Rosato R, Bertetto O, Molaschi M, Ciccone G. Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service. Critical Reviews in Oncology/Hematology 2008;68:157-64. [DOI: 10.1016/j.critrevonc.2008.07.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
579 Glade Bender J, Yamashiro DJ, Fox E. Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors. Oncologist 2011;16:1614-25. [PMID: 22042784 DOI: 10.1634/theoncologist.2011-0148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
580 Fiorentino A, Chiumento C, Fusco V. Do comorbidity influences acute toxicity and outcome in elderly patients with endometrial cancer treated by adjuvant radiotherapy plus brachytherapy? Clin Transl Oncol 2013;15:665-9. [PMID: 23359175 DOI: 10.1007/s12094-012-0986-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
581 Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, Montie JE, Lee CT, Wood DP Jr, Miller DC. Delays in diagnosis and bladder cancer mortality. Cancer 2010;116:5235-42. [PMID: 20665490 DOI: 10.1002/cncr.25310] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 9.3] [Reference Citation Analysis]
582 Choi JH, Lee SH, Choi YH, You MS, Shin BS, Paik WH, Ryu JK, Kim YT. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: A single-center experience of 214 patients. Hepatobiliary Pancreat Dis Int 2019;18:562-8. [PMID: 31551143 DOI: 10.1016/j.hbpd.2019.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
583 Moe MM, Pwint TP, Leonard R. Treatment options for older woman with early breast cancer. Expert Review of Anticancer Therapy 2014;6:941-50. [DOI: 10.1586/14737140.6.6.941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
584 Alibhai SM. Comprehensive geriatric assessment in older patients with cancer: two steps forward? J Geriatr Oncol 2013;4:205-7. [PMID: 24070458 DOI: 10.1016/j.jgo.2013.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
585 Duberstein PR, Chen M, Chapman BP, Hoerger M, Saeed F, Guancial E, Mack JW. Fatalism and educational disparities in beliefs about the curability of advanced cancer. Patient Educ Couns 2018;101:113-8. [PMID: 28716485 DOI: 10.1016/j.pec.2017.07.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
586 Wang C, Sturgis EM, Chen X, Wei Q, Li G. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer. Oncotarget 2016;7:34472-9. [PMID: 27121322 DOI: 10.18632/oncotarget.8908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
587 Lekovic D, Gotic M, Perunicic-jovanovic M, Vidovic A, Bogdanovic A, Jankovic G, Cokic V, Milic N. Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis. Med Oncol 2014;31. [DOI: 10.1007/s12032-014-0869-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
588 van de Schans S, Wymenga A, van Spronsen D, Schouten H, Coebergh J, Janssen-heijnen M. Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Annals of Oncology 2012;23:1280-6. [DOI: 10.1093/annonc/mdr411] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
589 Sarfati D, Gurney J, Stanley J, Salmond C, Crampton P, Dennett E, Koea J, Pearce N. Cancer-specific administrative data–based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. Journal of Clinical Epidemiology 2014;67:586-95. [DOI: 10.1016/j.jclinepi.2013.11.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
590 Visser O, van Leeuwen FE. Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands. Eur J Cancer 2005;41:2321-30. [PMID: 16125930 DOI: 10.1016/j.ejca.2005.03.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
591 Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M, Suárez C, Van der Poorten V, Hermans R, Rodrigo JP, Devaney KO. Future of the TNM classification and staging system in head and neck cancer. Head Neck. 2010;32:1693-1711. [PMID: 20191627 DOI: 10.1002/hed.21361] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
592 Johnson CB, Davis MK, Law A, Sulpher J. Shared Risk Factors for Cardiovascular Disease and Cancer: Implications for Preventive Health and Clinical Care in Oncology Patients. Canadian Journal of Cardiology 2016;32:900-7. [DOI: 10.1016/j.cjca.2016.04.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 10.6] [Reference Citation Analysis]
593 Wun T, White RH. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 2009;22:9-23. [PMID: 19285269 DOI: 10.1016/j.beha.2008.12.001] [Cited by in Crossref: 127] [Cited by in F6Publishing: 92] [Article Influence: 10.6] [Reference Citation Analysis]
594 Katz MH, Slack R, Bruno M, Mcmillan J, Fleming JB, Lee JE, Bednarski B, Papadopoulos J, Matin SF. Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of “TeleDischarge”. Journal of Surgical Research 2016;202:196-203. [DOI: 10.1016/j.jss.2015.12.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
595 Essa H, Dobson R, Wright D, Lip GYH. Hypertension management in cardio-oncology. J Hum Hypertens 2020;34:673-81. [PMID: 32747676 DOI: 10.1038/s41371-020-0391-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
596 Janssen-heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JWW. Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Critical Reviews in Oncology/Hematology 2005;55:231-40. [DOI: 10.1016/j.critrevonc.2005.04.008] [Cited by in Crossref: 259] [Cited by in F6Publishing: 224] [Article Influence: 16.2] [Reference Citation Analysis]
597 Arthur AE, Peterson KE, Rozek LS, Taylor JM, Light E, Chepeha DB, Hébert JR, Terrell JE, Wolf GT, Duffy SA; UM Head and Neck SPORE Program. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis. Am J Clin Nutr 2013;97:360-8. [PMID: 23269814 DOI: 10.3945/ajcn.112.044859] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
598 Siu M, Catton P, Jones J, Jadad AR. A pilot study examining the unmet needs of cancer survivors living with polypathology. Curr Oncol 2013;20:e266-9. [PMID: 23737696 DOI: 10.3747/co.20.1307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
599 Bugter O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, Wieringa MH, Verduijn GM, Mureau MAM, Ten Hove I, van Meerten E, Hardillo JA, Baatenburg de Jong RJ. Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable. Head Neck 2019;41:1648-55. [PMID: 30652377 DOI: 10.1002/hed.25595] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
600 Hall SF, Groome PA, Irish J, O'sullivan B. The Natural History of Patients With Squamous Cell Carcinoma of the Hypopharynx. Laryngoscope 2008;118:1362-71. [DOI: 10.1097/mlg.0b013e318173dc4a] [Cited by in Crossref: 98] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
601 Guo R, Chen XZ, Chen L, Jiang F, Tang LL, Mao YP, Zhou GQ, Li WF, Liu LZ, Tian L, Lin AH, Ma J. Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: development and validation of a predictive score model. Radiother Oncol 2015;114:249-56. [PMID: 25618213 DOI: 10.1016/j.radonc.2014.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
602 Proctor S, Wilkinson J. A web-based study concept designed to progress clinical research for ‘orphan’ disease areas in haematological oncology in the elderly: The SHIELD programme. Critical Reviews in Oncology/Hematology 2007;61:79-83. [DOI: 10.1016/j.critrevonc.2006.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
603 Pauli N, Svensson U, Karlsson T, Finizia C. Exercise intervention for the treatment of trismus in head and neck cancer – a prospective two-year follow-up study. Acta Oncologica 2016;55:686-92. [DOI: 10.3109/0284186x.2015.1133928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
604 Fairey A, Chetner M, Metcalfe J, Moore R, Todd G, Rourke K, Voaklander D, Estey E. Associations Among Age, Comorbidity and Clinical Outcomes After Radical Cystectomy: Results From the Alberta Urology Institute Radical Cystectomy Database. Journal of Urology 2008;180:128-34. [DOI: 10.1016/j.juro.2008.03.057] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
605 Paulino Pereira NR, Janssen SJ, van Dijk E, Harris MB, Hornicek FJ, Ferrone ML, Schwab JH. Development of a Prognostic Survival Algorithm for Patients with Metastatic Spine Disease. The Journal of Bone and Joint Surgery 2016;98:1767-76. [DOI: 10.2106/jbjs.15.00975] [Cited by in Crossref: 66] [Cited by in F6Publishing: 16] [Article Influence: 13.2] [Reference Citation Analysis]
606 Shinkawa H, Tanaka S, Takemura S, Amano R, Kimura K, Nishioka T, Miyazaki T, Kubo S. Predictive Value of the Age-Adjusted Charlson Comorbidity Index for Outcomes After Hepatic Resection of Hepatocellular Carcinoma. World J Surg 2020;44:3901-14. [PMID: 32651603 DOI: 10.1007/s00268-020-05686-w] [Reference Citation Analysis]
607 Seve P, Ray-Coquard I, Trillet-Lenoir V, Sawyer M, Hanson J, Broussolle C, Negrier S, Dumontet C, Mackey JR. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer 2006;107:2698-705. [PMID: 17063500 DOI: 10.1002/cncr.22300] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
608 Sarfati D, Hill S, Blakely T, Robson B, Purdie G, Dennett E, Cormack D, Dew K. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer 2009;9:116. [PMID: 19379520 DOI: 10.1186/1471-2407-9-116] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 6.5] [Reference Citation Analysis]
609 Ye F, Moon DH, Carpenter WR, Reeve BB, Usinger DS, Green RL, Spearman K, Sheets NC, Pearlstein KA, Lucero AR, Waddle MR, Godley PA, Chen RC. Comparison of Patient Report and Medical Records of Comorbidities: Results From a Population-Based Cohort of Patients With Prostate Cancer. JAMA Oncol 2017;3:1035-42. [PMID: 28208186 DOI: 10.1001/jamaoncol.2016.6744] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
610 François E, Azria D, Gourgou-Bourgade S, Jarlier M, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, Seitz JF, Conroy T, Juzyna B, Gerard JP. Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy. Radiother Oncol 2014;110:144-9. [PMID: 24418359 DOI: 10.1016/j.radonc.2013.10.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
611 Roxburgh CSD, Platt JJ, Leitch EF, Kinsella J, Horgan PG, Mcmillan DC. Relationship Between Preoperative Comorbidity, Systemic Inflammatory Response, and Survival in Patients Undergoing Curative Resection for Colorectal Cancer. Ann Surg Oncol 2011;18:997-1005. [DOI: 10.1245/s10434-010-1410-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
612 Rice LJ, Jefferson M, Briggs V, Delmoor E, Johnson JC, Gattoni-Celli S, Savage SJ, Lilly M, Prasad SM, Kittles R, Halbert CH. Discordance in perceived risk and epidemiological outcomes of prostate cancer among African American men. Prev Med Rep 2017;7:1-6. [PMID: 28507891 DOI: 10.1016/j.pmedr.2017.04.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
613 de Decker L, Campone M, Retornaz F, Berrut G, Kabeshova A, Molinié F, Beauchet O. Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study. PLoS One 2014;9:e98127. [PMID: 24848085 DOI: 10.1371/journal.pone.0098127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
614 Garg T, Young AJ, O’keeffe‐rosetti M, Mcmullen CK, Nielsen ME, Kirchner HL, Murphy TE. Association between treatment of superficial bladder cancer and 10‐year mortality in older adults with multiple chronic conditions. Cancer 2018;124:4477-85. [DOI: 10.1002/cncr.31705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
615 Pallis AG, Fortpied C, Wedding U, Van Nes MC, Penninckx B, Ring A, Lacombe D, Monfardini S, Scalliet P, Wildiers H. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 2010;46:1502-1513. [PMID: 20227872 DOI: 10.1016/j.ejca.2010.02.022] [Cited by in Crossref: 227] [Cited by in F6Publishing: 150] [Article Influence: 20.6] [Reference Citation Analysis]
616 Chen Y, Xu R. Mining cancer-specific disease comorbidities from a large observational health database. Cancer Inform 2014;13:37-44. [PMID: 25392682 DOI: 10.4137/CIN.S13893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
617 Satkunasivam R, Lo M, Stern M, Gill IS, Fleming S, Wu XC, Anderson RT, Thompson TD, Hamilton AS. The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators. Am J Clin Oncol 2018;41:1076-82. [PMID: 29668486 DOI: 10.1097/COC.0000000000000442] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
618 Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer. J Cachexia Sarcopenia Muscle 2018;9:505-13. [PMID: 29479839 DOI: 10.1002/jcsm.12279] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
619 Zhang F, Sturgis EM, Sun Y, Zhang Y, Wei Q, Zhang C, Zheng H, Li G. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy. Int J Cancer 2015;137:2454-61. [PMID: 25976983 DOI: 10.1002/ijc.29604] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
620 Zafar SY, Malin JL, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig LL, Weeks JC, Fouad MN, Ayanian JZ. Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer. 2011;11:354. [PMID: 21846341 DOI: 10.1186/1471-2407-11-354] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
621 Woldu SL, Sanli O, Clinton TN, Lotan Y. Validating the predictors of outcomes after radical cystectomy for bladder cancer: Predicting Radical Cystectomy Outcomes. Cancer 2019;125:223-31. [DOI: 10.1002/cncr.31799] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
622 Xing D, Tiong A, Bressel M, Rischin D, Tran P, Corry J. Outcomes of curative (chemo)radiotherapy for patients with non-p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment. J Med Imaging Radiat Oncol 2020;64:271-8. [PMID: 32037733 DOI: 10.1111/1754-9485.12995] [Reference Citation Analysis]
623 Villavicencio A, Solans M, Zacarías-Pons L, Vidal A, Puigdemont M, Roncero JM, Saez M, Marcos-Gragera R. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study. Int J Environ Res Public Health 2021;18:E701. [PMID: 33467494 DOI: 10.3390/ijerph18020701] [Reference Citation Analysis]
624 Lin CC, Virgo KS, Robbins AS, Jemal A, Ward EM. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER–Medicare Database. Ann Surg Oncol 2016;23:4139-48. [DOI: 10.1245/s10434-016-5508-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
625 Nanda A, Chen M, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'amico AV. Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 2010;77:147-52. [DOI: 10.1016/j.ijrobp.2009.04.085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
626 Backemar L, Djärv T, Wikman A, Johar A, Ross P, Lagergren P, Lagergren J. The role of diabetes and other co-morbidities on survival after esophageal cancer surgery in a population-based study. The American Journal of Surgery 2013;206:539-43. [DOI: 10.1016/j.amjsurg.2013.01.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
627 Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood. 2007;110:4606-4613. [PMID: 17873123 DOI: 10.1182/blood-2007-06-096966] [Cited by in Crossref: 245] [Cited by in F6Publishing: 205] [Article Influence: 17.5] [Reference Citation Analysis]
628 Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Yumen O, Bernath AM. Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 2006;7:59-66. [PMID: 16764745 DOI: 10.3816/CBC.2006.n.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
629 Nechuta S, Lu W, Zheng Y, Cai H, Bao PP, Gu K, Zheng W, Shu XO. Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat 2013;139:227-35. [PMID: 23605082 DOI: 10.1007/s10549-013-2521-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
630 Zheng Y, Huang Y, Zheng X, Peng J, Chen Y, Yu K, Yang Y, Wang X, Yang X, Qian J, Wang X, Gao X, Wu B. Deaths from COPD in patients with cancer: a population-based study. Aging (Albany NY) 2021;13:12641-59. [PMID: 33910167 DOI: 10.18632/aging.202939] [Reference Citation Analysis]
631 Lamont EB. A demographic and prognostic approach to defining the end of life. J Palliat Med 2005;8 Suppl 1:S12-21. [PMID: 16499460 DOI: 10.1089/jpm.2005.8.s-12] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
632 Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol 2016;34:1270-7. [PMID: 26884579 DOI: 10.1200/JCO.2015.65.0739] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 6.6] [Reference Citation Analysis]
633 Rose BS, Chen MH, Wu J, Braccioforte MH, Moran BJ, Doseretz DE, Katin MJ, Ross RH, Salenius SA, D'Amico AV. Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality. Int J Radiat Oncol Biol Phys 2016;96:778-84. [PMID: 27788950 DOI: 10.1016/j.ijrobp.2016.08.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
634 Suh WN, Kong KA, Han Y, Kim SJ, Lee SH, Ryu YJ, Lee JH, Shim SS, Kim Y, Chang JH. Risk factors associated with treatment refusal in lung cancer. Thorac Cancer 2017;8:443-50. [PMID: 28627788 DOI: 10.1111/1759-7714.12461] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
635 Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006;24:1112-1118. [PMID: 16505431 DOI: 10.1200/jco.2005.04.2150] [Cited by in Crossref: 225] [Cited by in F6Publishing: 78] [Article Influence: 15.0] [Reference Citation Analysis]
636 Gugliotta G, Castagnetti F, Fogli M, Cavo M, Baccarani M, Rosti G. Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors. Expert Rev Hematol 2013;6:563-74. [PMID: 24083631 DOI: 10.1586/17474086.2013.837279] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
637 Pal SK, Vanderwalde A, Hurria A, Figlin RA. Systemic therapies for metastatic renal cell carcinoma in older adults. Drugs Aging 2011;28:635-49. [PMID: 21812499 DOI: 10.2165/11592880-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
638 Lee JJ, Thompson ZS, Piccirillo JF, Klatt-Cromwell CN, Orlowski HLP, Kallogjeri D, Pipkorn P, Schneider JS. Risk Factors for Patient-Reported Olfactory Dysfunction After Endoscopic Transsphenoidal Hypophysectomy. JAMA Otolaryngol Head Neck Surg 2020;146:621-9. [PMID: 32379292 DOI: 10.1001/jamaoto.2020.0673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
639 van de Schans S, Janssen-heijnen M, Biesma B, Smeenk F, van de Poll-franse L, Seynaeve C, Coebergh J. COPD in cancer patients: Higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. European Journal of Cancer 2007;43:2194-202. [DOI: 10.1016/j.ejca.2007.08.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
640 Lee JH, Wu HG, Kim HJ, Kim DW, Lee SH, Kim TM, Kim YW, Heo DS. Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients. Cancer Res Treat 2012;44:242-50. [PMID: 23341788 DOI: 10.4143/crt.2012.44.4.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
641 Denbo JW, Slack RS, Bruno M, Cloyd JM, Prakash L, Fleming JB, Kim MP, Aloia TA, Vauthey J, Lee JE, Katz MHG. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis. J Gastrointest Surg 2017;21:636-46. [DOI: 10.1007/s11605-016-3340-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
642 Nugent EK, Hoff JT, Gao F, Massad LS, Case A, Zighelboim I, Mutch DG, Thaker PH. Wound complications after gynecologic cancer surgery. Gynecologic Oncology 2011;121:347-52. [DOI: 10.1016/j.ygyno.2011.01.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
643 Smith AW, Reeve BB, Bellizzi KM, Harlan LC, Klabunde CN, Amsellem M, Bierman AS, Hays RD. Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev. 2008;29:41-56. [PMID: 18773613 DOI: 10.1007/s11764-016-0553-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
644 Sussman J, Baldwin LM. The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr 2010;2010:18-24. [PMID: 20386050 DOI: 10.1093/jncimonographs/lgq007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
645 Nelson RA, Vogelzang N, Pal SK. A gap in disease-specific survival between younger and older adults with de novo metastatic renal cell carcinoma: results of a SEER database analysis. Clin Genitourin Cancer 2013;11:303-10. [PMID: 23647940 DOI: 10.1016/j.clgc.2013.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
646 Shanafelt T. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers. Hematology 2013;2013:158-67. [DOI: 10.1182/asheducation-2013.1.158] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
647 Kim DW, Chen MH, Wu J, Huland H, Graefen M, Tilki D, D'Amico AV. Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer. Cancer 2021;127:2222-8. [PMID: 34101827 DOI: 10.1002/cncr.33503] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
648 van der Schroeff MP, van de Schans SA, Piccirillo JF, Langeveld TP, Baatenburg de Jong RJ, Janssen-Heijnen ML. Conditional relative survival in head and neck squamous cell carcinoma: Permanent excess mortality risk for long-term survivors. Head Neck 2010;32:1613-8. [PMID: 20310043 DOI: 10.1002/hed.21369] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
649 Lee YG, Lee E, Kim I, Lee KW, Kim TM, Lee SH, Kim DW, Heo DS. Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer. Cancer Res Treat 2015;47:670-5. [PMID: 25672586 DOI: 10.4143/crt.2014.045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
650 Vamvakas L, Saloustros E, Karampeazis A, Georgoulias V. Advanced non-small-cell lung cancer in the elderly. Clin Lung Cancer 2009;10:158-67. [PMID: 19443335 DOI: 10.3816/CLC.2009.n.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
651 Mohile SG, Klepin HD, Rao AV. Considerations and controversies in the management of older patients with advanced cancer. Am Soc Clin Oncol Educ Book 2012;:321-8. [PMID: 24451757 DOI: 10.14694/EdBook_AM.2012.32.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
652 Townsend M, Kallogjeri D, Scott-Wittenborn N, Gerull K, Jansen S, Nussenbaum B. Multidisciplinary Clinic Management of Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 2017;143:1213-9. [PMID: 29075744 DOI: 10.1001/jamaoto.2017.1855] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
653 Grammatica A, Piazza C, Pellini R, Montalto N, Lancini D, Vural A, Barbara F, Ferrari M, Nicolai P. Free Flaps for Advanced Oral Cancer in the "Older Old" and "Oldest Old": A Retrospective Multi-Institutional Study. Front Oncol 2019;9:604. [PMID: 31334124 DOI: 10.3389/fonc.2019.00604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
654 Biggar RJ, Engels EA, Ly S, Kahn A, Schymura MJ, Sackoff J, Virgo P, Pfeiffer RM. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005;39:293-9. [PMID: 15980688 DOI: 10.1097/01.qai.0000164033.02947.e3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 6.0] [Reference Citation Analysis]
655 Hamilton AS, Wu XC, Lipscomb J, Fleming ST, Lo M, Wang D, Goodman M, Ho A, Owen JB, Rao C, German RR. Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer. J Natl Cancer Inst Monogr 2012;2012:213-20. [PMID: 23271776 DOI: 10.1093/jncimonographs/lgs033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
656 Nilssen Y, Strand TE, Wiik R, Bakken IJ, Yu XQ, O'Connell DL, Møller B. Utilizing national patient-register data to control for comorbidity in prognostic studies. Clin Epidemiol 2014;6:395-404. [PMID: 25368532 DOI: 10.2147/CLEP.S70742] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
657 Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, McCleary NJ, Meyerhardt JA, Niland J, Kahn KL. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012;30:2624-2634. [PMID: 22665536 DOI: 10.1200/jco.2011.41.1140] [Cited by in Crossref: 152] [Cited by in F6Publishing: 68] [Article Influence: 16.9] [Reference Citation Analysis]
658 Gross JH, Townsend M, Hong HY, Miller E, Kallogjeri D, Zenga J, Pipkorn P, Jackson RS, Haughey B, Rich JT. Predictors of swallow function after transoral surgery for locally advanced oropharyngeal cancer. The Laryngoscope 2019;130:94-100. [DOI: 10.1002/lary.27856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
659 Katsi V, Magkas N, Georgiopoulos G, Athanasiadi E, Virdis A, Masi S, Kliridis P, Hatziyanni A, Tsioufis C, Tousoulis D. Arterial hypertension in patients under antineoplastic therapy: a systematic review. J Hypertens 2019;37:884-901. [PMID: 30624368 DOI: 10.1097/HJH.0000000000002006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 13.0] [Reference Citation Analysis]
660 Steyerberg EW, Neville BA, Koppert LB, Lemmens VE, Tilanus HW, Coebergh JW, Weeks JC, Earle CC. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 2006;24:4277-84. [PMID: 16963730 DOI: 10.1200/JCO.2005.05.0658] [Cited by in Crossref: 170] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
661 Nugent EK, Case AS, Hoff JT, Zighelboim I, Dewitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS. Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors. Gynecologic Oncology 2010;116:438-41. [DOI: 10.1016/j.ygyno.2009.09.045] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
662 Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche H. Comorbidity and Performance Indices as Predictors of Cancer-Independent Mortality But Not of Cancer-Specific Mortality After Radical Cystectomy for Urothelial Carcinoma of the Bladder. European Urology 2012;62:662-70. [DOI: 10.1016/j.eururo.2012.03.057] [Cited by in Crossref: 68] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
663 Bergström L, Ward EC, Finizia C. Voice rehabilitation for laryngeal cancer patients: Functional outcomes and patient perceptions: Voice Rehabilitation Postradiotherapy. The Laryngoscope 2016;126:2029-35. [DOI: 10.1002/lary.25919] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
664 Ferrandina G, Lucidi A, Paglia A, Corrado G, Macchia G, Tagliaferri L, Fanfani F, Morganti AG, Valentini V, Scambia G. Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications. Eur J Surg Oncol 2012;38:238-44. [PMID: 22200246 DOI: 10.1016/j.ejso.2011.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
665 Keane FK, Chen M, Zhang D, Loffredo MJ, Kantoff PW, Renshaw AA, D'amico AV. The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease: PC Death in Intermediate-Risk Disease. Cancer 2014;120:1787-93. [DOI: 10.1002/cncr.28609] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29]